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Abstract 
 
Background Despite a rapidly growing body of research, a systematic evidence compilation of the risk and 
protective factors for middle- and long-distance running-related injury (RRI) is currently lacking. 
Objectives To compile the evidence about modifiable and non-modifiable training-related and behavioural risk and 
protective factors. 
Data sources Five databases (PubMed; CINAHL; MEDLINE; SPORTDiscus; and PsycINFO) were searched for the 
dates 01 January 1970 to 31 December 2015, inclusive, for original peer-reviewed articles.  
Study selection The eligible designs were cross-sectional, case-control, longitudinal observational studies, and 
randomised controlled trials involving runners competing at distances from ≥800m to ≤42.2km.  Outcomes were any 
specific and/or general RRI, and exposures included training-related and behavioural factors. 
Study appraisal and synthesis methods Authors and date, study design, injury type(s), descriptors and comparators 
for each exposure, and results and measures of association were extracted from the selected studies.  Methodological 
quality was independently appraised using two separate checklists; a modified checklist for observational study 
designs, and the PEDro scale for randomised controlled trials.   
Results Among 73 eligible articles for inclusion, 19 (26.0%) and 30 (41.0%) were of high or satisfactory 
methodological quality, respectively.  As a non-modifiable exposure, a history of previous injury was found to be 
associated with an increased risk of both general and specific RRI.  In terms of modifiable exposures, irregular 
and/or absent menstruation was found to be associated with an increased risk of stress fracture development, 
whereas the use of oral contraceptives was found to be associated with a decreased risk.   
Limitations Due to high clinical, methodological, and statistical heterogeneity, it was not feasible to estimate a 
pooled effect size across similar studies.  
Conclusions A history of previous injury was associated with an increased risk of both general and specific RRI. 
The use of oral contraceptives was found to be associated with a decreased risk of skeletal stress fracture.  
Conversely, irregular and/or absent menstruation was associated with an increased risk.  The varied effect directions 
and/or a number of statistically insignificant results associated with the majority of factors hindered the ability to 
draw any definitive conclusions about their relationship to RRI risk.
Key points  
#1 The identification of modifiable and non-modifiable risk and protective factors for distance running-related 
injury is a necessary step for better understanding how to design and deliver injury prevention interventions. 
 
#2 A history of previous injury is a strong non-modifiable risk factor for distance running-related injury.  Future 
studies are required to better understand why and how previous injury contributes to the development of subsequent 
injury. 
 
#3 The use of oral contraceptives is a modifiable protective factor for stress fracture development in female runners.  
Irregular or absent menstruation increased the risk of the same injury.  More studies are required to investigate how 
key exposures associated with the female athlete triad interact and affect the risk of distance running-related injury. 
 
# 4 Varied effect directions and a number of statistically insignificant results associated with the majority of factors 
hindered the ability to draw any definitive conclusions about their relationship to running-related injury risk.
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1.0 Introduction 
Distance running is an ideal form of exercise for many able-bodied individuals in a variety of locations.  Indeed, 
the physiological and psychological benefits associated with running are well accepted [1].  Unfortunately, the 
positives of this activity are offset by the risk of sustaining a running-related injury (RRI).  Depending on the 
population sample and length of follow-up, the RRI incidence rate reportedly ranges from 2.5 to 33.0 injuries 
per 1000 hours of running [2].  Over a lifetime recall period, the pain-related injury incidence proportion for 
cross-country runners has recently been found to reach 94.4% [3].   
The increasing popularity of running, combined with reports of a high risk of sustaining a RRI, has inspired 
many scientific investigations over the last forty-five years.  Several descriptive [4-10] and systematic reviews 
[1, 11-17] have attempted to summarise the available evidence on factors that are associated with RRI.  The first 
major systematic review included 17 studies [11].  Unlike subsequent papers [13, 15, 16], that review did not 
adapt its methodological quality checklist to the target context.  A later review that included 31 articles did not 
include middle-distance running samples, and only commented on a limited number of training-related and 
behavioural risk factors [13].  More recently, Saragiotto et al [15] identified 60 different predictive factors for 
RRI across 11 articles, but did not include studies that had investigated specific musculoskeletal pathologies.  
The most recent systematic reviews have been very focused, addressing the influence of sex [16] and vertical 
ground reaction forces on RRI risk [17]. 
In light of existing research investigating RRI aetiology, there is a need for a review that does not exclude 
particular study designs or injuries.  Even though certain epidemiological study designs are temporally 
ambiguous regarding causality, including them is now required in order to consider the whole body of evidence 
in the area so that novel theories and hypotheses can be generated.  An appropriate starting point for such an 
effort is to compile the evidence on the effect of training-related and behavioural factors on RRI risk.  This 
would mean excluding kinetic, kinematic and isokinetic factors, each of which instead necessitate their own 
systematic reviews with a specific and well-defined research question e.g. [12, 17].  With biomechanical factors 
excepted, it is possible to categorise training-related and behavioural factors according to whether or not they 
are amenable to modification.  Such a delineation has important theoretical and practical implications for the 
type of population-based RRI prevention program or strategy that is to be implemented or used [18].  Therefore, 
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the purpose of this systematic review was to compile the evidence about modifiable and non-modifiable 
training-related and behavioural risk and protective factors. 
2.0 Methods 
2.1 Electronic search 
Five databases (PubMed; CINAHL; MEDLINE; SPORTDiscus; and PsycINFO) were searched by the first 
author for the dates 01 January 1970 to 31 December 2013, inclusive.  Updated searches across all databases 
were later conducted to retrieve further potential articles published between 01 January 2014 to 31 December 
2015.  Citation software (EndNote for Windows 6.0.1) and advice from a university librarian facilitated the 
searching process.  Database search strategies, including key words and Medical Subject Heading (MeSH) 
terms, can be viewed in the Electronic Supplementary Material (ESM) Table S1. 
2.2 Eligibility criteria 
Eligible running distances studied ranged from ≥800m to ≤42.2km in accordance with the International 
Association of Athletics Federation’s (IAAF) middle- and long-distance running definitions [19].  These events 
distinguish middle- and long-distance running from other similar athletic disciplines, including both sprinting 
and extreme endurance running (i.e. ultra-marathons). 
2.2.1 Inclusion and exclusion criteria 
To be eligible for inclusion, the studies had to comply with the following criteria: (i) study designs were cross-
sectional, case-control, or longitudinal (i.e. both retrospective and prospective cohort studies) along with 
randomised controlled trials (RCTs); (ii) the study sample represented middle- and long-distance runners as per 
the above IAAF definition (section 2.2); (iii) exposures included training-related and/or behavioural factors; (iv) 
the outcome was any specific and/or general RRI; (v) inferential statistical analyses with measures of 
association between exposures and RRI were reported (e.g. crude and/or adjusted analyses including, but not 
limited to, mean/median statistical difference, odds ratio (OR), relative risk (RR), cumulative risk difference 
(cRD), hazard ratio (HR) with 95% confidence intervals); and, (vi) original peer-reviewed academic journal 
articles published in English.   
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After executing a primary search and implementing the above eligibility criteria, one author (AH) inspected the 
titles and abstracts of all retrieved articles.  For the remaining eligible articles, the bibliography within each 
article was manually hand searched to identify potential new articles that were missed via the primary search 
strategy.  Two authors (AH and RN) independently evaluated the suitability of each article in accordance with 
the above criteria.  Disagreements were resolved via a consensus meeting.  
2.3 Data extraction and evidence interpretation  
The following information and data were extracted from eligible studies: (i) authors and date; (ii) study design; 
(iii) injury type; (iv) descriptors and comparators for each exposure; and, (v) results and measures of 
association.  All data were extracted by one author and re-examined by all authors, each of whom had been 
allocated a unique role to ensure data accuracy.  Regarding the interpretation of both statistically significant and 
non-significant data, we assessed the strength of epidemiological association risk ratios according to the criteria 
in Table 1 (apply only to relative and not absolute measures of association). 
Table 1 Criteria for assessing the strength of epidemiological associations. Adapted from Craun and Calderon 
for the World Health Organisation [20], with permission. 
Risk ratio (increased risk) Risk ratio (decreased risk) Strength of association 
1.0 1.0 (Reference) 
1.01-1.20 0.80-0.99 Weak 
1.21-1.50 0.50-0.79 Moderate 
>1.51 <0.49 Strong 
 
2.4 Quality assessment  
Two checklists were used for assessing the methodological quality of included articles: (i) a modified version of 
an existing methodological quality assessment checklist for observational study designs [13]; and (ii) the 
Physiotherapy Evidence Database (PEDro) scale for RCTs [21].  The former checklist includes 12 items across 
four categories: (i) study objective; (ii) study population; (iii) outcome measurements; and, (iv) data presentation 
and analyses.  There were 10, 11 and 12 items according to whether the study design was case-control, cross-
sectional, or cohort, respectively (ESM Table S2).  The PEDro scale was expanded with the addition of a single 
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item, which was concerned with RRI definitions (ESM Table S3).  We considered a score of ≥50.0% as an 
indication of satisfactory methodological quality, whereas a score of ≥75.0% was deemed high quality [3, 22].  
Two authors (AH and EV) independently assessed the quality of each article and awarded each item a positive 
(+) or negative (-) score.  In cases of disagreement, a consensus meeting resolved any discrepancies.   
3.0 Results 
3.1 Full-text selection 
After searching five databases, a total of 3,572 articles were identified.  After removing 561 duplicates and 
examining 3,011 titles and abstracts, 97 potentially relevant full-text articles were retained.  A manual search of 
the 97 reference lists produced a further 48 articles, and these were added to the search process.  Closely 
inspecting 145 full-texts excluded another 79 articles.  The literature search resulted in a total of 73 articles for 
the evidence compilation (Figure 1). 
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3,572 articles identified by literature search 
 2,784 PubMed 
 166 CINAHL 
 311 MEDLINE  
 287 SPORTDiscus 
 24 PsycINFO 
 
561 duplicate articles excluded 
 
3,011 articles eligible  
 
2,914 articles excluded after title and 
abstract screen 
 
97 articles eligible  
 
79 articles excluded 
 25 inappropriate sample 
 23 applied clinical biomechanics 
 4 unable to identify sample 
 13 analyses not appropriate or absent 
 13 case series 
 1 case study (n=1) 
 
 
 
 
Manual search of 97 bibliographies produced a further 160 
potential articles 
 
145 eligible articles 
 
66 full-text articles included  
 
Out of 160 potential articles, 48 were considered relevant 
 
7 articles found with an updated literature search 
 
73 articles included in review 
 
Figure 1 Visualisation of the systematic searching process 
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3.2 Study characteristics 
The composition of the included study designs was as follows: (i) eight RCTs; (ii) 26 prospective cohorts; (iii) 
three retrospective cohorts; (iv) three case-control studies; (iv) 27 cross-sectional two group comparisons; and, 
(v) six cross-sectional three group comparisons.  In terms of publication distribution over time, no eligible 
articles were published between 1970 to 1979, but 25 were published during 1980 to 2000, inclusive.  In the 
most recent 15 years, 48 articles were published. 
3.3 Quality assessment 
Across the 73 included studies, the level of inter-rater agreement of quality assessment was high, kappa statistic 
(k) = 0.92.  The respective mean and median quality score for each study design was as follows: (i) RCT = 
63.5% and 66.6% (range: 41.6% to 91.6%); (ii) prospective cohort = 73.3% and 75.0% (range: 33.3% to 
91.6%); (iii) retrospective cohort = 58.3% and 50.0% (range: 41.6% to 83.3%); (iv) case-control = 40.0% and 
40.0% (range: 30.0% to 50.0%); (v) cross-sectional two group comparison = 52.8% and 54.5% (range: 18.1% to 
81.8%); and, (vi) cross-sectional three group comparison = 49.9% and 54.5% (range: 27.2% to 63.6%).  Overall, 
19 (26.0%) and 30 (41.0%) studies were of high (≥75.0%) and satisfactory (≥50.0%) methodological quality, 
respectively (Table 2).   
For RCTs, items five, six and seven generally received the lowest scores, and represent whether participants, 
therapists and/or assessors were blind with regard to intervention allocation.  For the prospective cohort study 
designs, a lower overall score was found for item eight, in that the follow-up period was <12 months.  Overall, 
case-control study designs did not meet the satisfactory level of quality due to low scores for items nine and 10, 
indicating that the recall period was not reported, nor was a clear definition of injury provided.  The 
unanimously low score for item 11 indicates that therapists and statistical analysts were aware of the injury 
status or variable coding when performing physical examinations or working with data, respectively.  
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Table 2 Observational study quality scores ordered by decreasing rank 
  Methodological quality criteria a 
Study Design 1 2 3 4 5 6 7 8 9 10 11 12 13 Score (%) 
Macera et al (1989) [23] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Walter et al (1989) [24] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Kelsey et al (2007) [25] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Nielsen et al (2013) [26] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Nielsen et al (2013) [27] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Nielsen et al (2014) [28] PC + + + + + + + + n/a + - + + 11/12 (91.6) 
Wen et al (1998) [29] PC + + + + + + + - n/a + - + + 10/12 (83.3) 
Van Middelkoop et al (2008) [30] PC + + + + + + + - n/a + - + + 10/12 (83.3) 
Buist et al (2010) [31] PC + + + + + + + - n/a + - + + 10/12 (83.3) 
Hirschmüller et al (2012) [32] PC + - + + + + + + n/a + - + + 10/12 (83.3) 
Bredeweg et al (2013) [33] PC + + + + + + + - n/a + - + + 10/12 (83.3) 
Van Middelkoop et al (2007) [34] PC + + + + + - + - n/a + - + + 9/12 (75.0) 
Hespanhol Junior et al (2013) [35] PC + - + + + + + - n/a + - + + 9/12 (75.0) 
Malisoux et al (2013) [36] PC + + + + + - + - n/a + - + + 9/12 (75.0) 
Nielsen et al (2014) [37]  PC + + + + + + + - n/a - - + + 9/12 (75.0) 
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Kluitenberg et al (2015) [38] PC + - + + + + + - n/a + - + + 9/12 (75.0) 
Bennett et al (2012) [39] PC + + - + + - + - n/a + - + + 8/12 (66.6) 
Fields et al (1990) [40] PC + - - + + + + + n/a + - + - 8/12 (66.6) 
Buist et al (2010) [41] PC + + + + + - - - n/a + - + + 8/12 (66.6) 
Taunton et al (2003) [42] PC + + - - + + + - n/a + - + + 8/12 (66.6) 
Satterthwaite et al (1999) [43] PC + + - + + + - - n/a - - + + 7/12 (58.3) 
Reinking et al (2007) [44] PC + + + + + - + - n/a - - + - 7/12 (58.3) 
Thijs et al (2011) [45] PC + + - + - + + - n/a + - + - 7/12 (58.3)  
Van Ginckel et al (2009) [46] PC + - - + + - + - n/a + - + - 6/12 (50.0) 
Ghani Zadeh Hesar et al (2009) [47] PC + - - + - + + - n/a - - + - 5/12 (41.6) 
Thijs et al (2008) [48] PC + - - - + - + - n/a - - + - 4/12 (33.3) 
Hootman et al (2002) [49]  RC + + + + + + + + n/a + - + + 10/12 (83.3) 
Taunton et al (2002) [50]  RC - + - + - - - + n/a + - + + 6/12 (50.0) 
Warren & Davis (1988) [51] RC + + + - - - + - n/a - - + - 5/12 (41.6) 
Myburgh et al (1990) [52] CC + + + + n/a n/a + n/a - - - - - 5/10 (50.0) 
Miller et al (2007) [53] CC + - - + n/a n/a + n/a - - - + - 4/10 (40.0) 
Fredericson et al (2000) [54] CC + - - + n/a n/a + n/a - - - - - 3/10 (30.0) 
Henriksson et al (2000) [55] CS 3 group + + - + + n/a + n/a + - - + - 7/11 (63.6) 
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Barrow & Saha (1988) [56] CS 3 group + + + + + n/a - n/a + - - - - 6/11 (54.5) 
Ribeiro et al (2011) [57] CS 3 group + + + + - n/a + n/a - - - + - 6/11 (54.5) 
Ribeiro et al (2011) [58] CS 3 group + + + + - n/a + n/a - - - + - 6/11 (54.5) 
Ekenman et al (2001) [59] CS 3 group + + - - + n/a + n/a - - - + - 5/11 (45.4) 
Messier & Pittala (1988) [60] CS 3 group + - - - - n/a + n/a - - - + - 3/11 (27.2) 
Wen et al (1997) [61] CS 2 group  + - + + + n/a + n/a + + - + + 9/11 (81.8) 
Parker et al (2011) [62] CS 2 group + + - + + n/a + n/a + + - + + 9/11 (81.8) 
Marti (1988) [63] CS 2 group + + - + + n/a + n/a + + - + - 8/11 (72.7) 
Marti et al (1988) [64] CS 2 group + + - + + n/a + n/a + + - + - 8/11 (72.7) 
Rasmussen et al (2013) [65] CS 2 group + + - + + n/a + n/a - + - + + 8/11 (72.7) 
Lloyd et al (1986) [66] CS 2 group + + + + + n/a + n/a - - - + + 8/11 (72.7) 
McKean et al (2006) [67] CS 2 group + + - + + n/a + n/a + - - + + 8/11 (72.7) 
McKelvie & Valliant (1985) [68]  CS 2 group + + - + + n/a + n/a + - - + - 7/11 (63.6) 
Jacobs & Berson (1986) [69] CS 2 group + + - + + n/a + n/a + + - - - 7/11 (63.6) 
Gerlach et al (2005) [70] CS 2 group + - - + + n/a + n/a + + - + - 7/11 (63.6) 
Chang et al (2012) [71] CS 2 group + + - + + n/a + n/a - - - + + 7/11 (63.6) 
Haglund-Ȧkerlind et al (1993) [72] CS 2 group + - + + + n/a + n/a - - - + - 6/11 (54.5) 
Duffey et al (2000) [73] CS 2 group + - + + - n/a + n/a - + - + - 6/11 (54.5) 
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Bennell et al (2004) [74] CS 2 group + - + + - n/a + n/a + - - + - 6/11 (54.5) 
Lopes et al (2011) [75] CS 2 group + + + + + n/a + n/a - - - - - 6/11 (54.5) 
Valliant (1981) [76] CS 2 group + + - - + n/a + n/a - - - + - 5/11 (54.5) 
Messier et al (1995) [77] CS 2 group + - - + - n/a + n/a - + - + - 5/11 (54.5) 
Niemuth et al (2005) [78] CS 2 group + + - + - n/a + n/a - - - + - 5/11 (54.5) 
Marti & Rehmann (1987) [79] CS 2 group - + - - + n/a + n/a + - - - - 4/11 (36.3) 
Grimston et al (1991) [80] CS 2 group + - - - - n/a + n/a + - - - + 4/11 (36.3) 
Messier et al (1991) [81] CS 2 group + - - + - n/a + n/a - - - + - 4/11 (36.3) 
Reinking & Hayes (2006) [82] CS 2 group + - - - - n/a + n/a + - - + - 4/11 (36.3) 
McQuade (1986) [83] CS 2 group + - - - + n/a - n/a - - - + - 3/11 (27.2) 
McCrory et al (1999) [84] CS 2 group + - - - - n/a + n/a - - - + - 3/11 (27.2) 
Knobloch et al (2008) [85] CS 2 group - - + - - n/a - n/a - + - + - 3/11 (27.2) 
Caselli & Longobardi (1997) [86] CS 2 group - + - - + n/a - n/a - - - - - 2/11 (18.1) 
Fonseca et al (2015) [87] CS 2 group - + - - - n/a - n/a + - - - - 2/11 (18.1) 
PC, prospective cohort; RC, retrospective cohort; CC, case-control; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-sectional three group comparison; 
+/-, item scored positive or negative for a given study; n/a, not applicable; a quality assessment criteria: (1), study had a clearly defined purpose; (2), setting, locations, dates, 
and periods of recruitment reported; (3), main demographic features of the population reported; (4), eligibility criteria, and sampling methods/strategy reported; (5) numbers 
at each stage of the study were reported; (6), if participation at follow-up was >80% for periods of ≤6 months, or >60% for periods of ≥7 months; (7), methods used to collect 
data were reported (i.e. surveys, physical examinations procedure); (8), prospective observational follow-up period ≥12 months; (9), participants’ recall periods reported; 
(10), the injury definition and associated physical impairments were reported and discernible; (11), if the statistical analyses and/or exposure assessment occurred under 
blinding (i.e. blind physical assessment and concealed group coding); (12), if the statistical approach used was transparently reported; (13), adequate adjustment for 
covariates occurred via the use of a multivariable technique. Further information: item 9 was not applicable for PC studies; items 5,6 and 8 were not applicable for CC 
studies; and items 6 and 8 were not applicable for CS studies. A more detailed explanation for each item can be found in Electronic Supplementary Material Table S2 
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Table 3 PEDro quality of scores for randomised controlled trials ordered by decreasing rank 
  Criteria for assessing methodological quality a 
Study  1 2 3 4 5 6 7 8 9 10 11 12 Score (%) 
Theisen et al (2013) [88]  + + + + + + + + - + + + 11/12 (91.6) 
Cobb et al (2007) [89]  + + + + - - - + + + + + 9/12 (75.0) 
Buist et al (2008) [90]  + + + + - - - + + + + + 9/12 (75.0) 
Bredeweg et al (2012) [91]  + + + + - - - - + + + + 8/12 (66.6) 
Ryan et al (2014) [92]  + + - + - - - + + + + + 8/12 (66.6) 
Ryan et al (2010) [93]  - + + + - - - - - + + + 6/12 (50.0) 
Van Mechelen et al (1993) [94]  + - - + - - - - - + + + 5/12 (41.6) 
Jakobsen et al (1994) [95]  - - - + - - - + + + - + 5/12 (41.6) 
+/-, item scored positive or negative for a given study; a quality assessment criteria: (1), eligibility criteria were specified; (2), random allocation to groups; (3), allocation was 
concealed; (4), groups were similar at baseline; (5), blinding of participants; (6), blinding of therapists who administered the intervention; (7), blinding of assessors who 
measured at least one key outcome; (8), measures of at least one key outcome were obtained for >85% of participants initially allocated to groups; (9), intention-to-treat 
analyses were used; (10), the results of between-group statistical comparisons were reported; (11), the study provided both point measures and measures of variability for at 
least one key outcome; (12), the injury definition and associated physical impairments were reported and discernible.  A more detailed explanation for each item can be found 
in Electronic Supplementary Material Table S3 
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3.4 Modifiable risk and protective factors  
In the modifiable factor category, 12 sub-categories were identified: (i) distance; (ii) duration; (iii) frequency; 
(iv) pace and intervals; (v) weight; (vi) body mass index (BMI); (vii) diet and hormonal; (viii) footwear, insoles, 
and orthotics; (ix) terrain and surface; (x) stretching, warm-up, and cool down; (xi) psychological; and, (xii) 
other modifiable (i.e. factors that could not be appropriately sub-categorised) (Table 4).   
3.4.1 Distance  
Thirty-six studies examined distance or factors associated with distance (ESM Table S4).  The median 
methodological quality score for these studies was 63.6% (range: 18.1% to 91.6%) with two RCTs and nine 
prospective cohort studies scoring ≥75.0%.  Running distance data were handled differently across studies, and 
either dichotomised (e.g. high vs. low), categorised, or expressed as a discrete unit change (i.e. increase or 
decrease in 1.0km or 10.0km per week).  In total, 17 studies found a statistically significant relationship between 
increasing and/or decreasing distance and either general [22-24, 36, 65, 66, 69, 76, 79, 83, 86] or specific RRI 
[43, 61, 72, 77, 81, 85].  
The RCT by Theisen et al [88] did not find a statistically significant association between a 1.0km unit increase 
per week and general RRI in their adjusted analyses.  Similarly, Kelsey et al [25] analysed the effect of absolute 
distance on stress fracture development in female runners and found little evidence that a 10.0km unit increase 
per week significantly affected risk.  The high quality prospective cohort studies by Macera et al [23] and 
Walter et al [24] both provide strong evidence that a weekly distance of ≥64km increases the risk of RRI.  The 
latter study also found a 2.5 fold greater risk for males running >8km during their weekly long run versus <8km.  
Conversely, the high quality prospective investigation by Malisoux et al [36] found weak evidence that a 1.0km 
unit increase in distance per session significantly decreased the risk of RRI after covariate adjustment.  
Likewise, a 10.0km unit decrease per week significantly increased the risk of knee pain [43], and a weekly 
distance of <30km (reference 30-60km) doubled the risk of general RRI [65].  The two studies to examine 
relative changes in distance over time were clinically interesting given that both found a greater risk of injury if 
the running distance increased by >10% and >30% over a 13 week and two week period, respectively [28, 90].   
Despite four prospective cohort studies and 10 cross-sectional studies supporting that higher distances increase 
general and specific RRI risk [22-24, 43, 61, 66, 69, 72, 76, 77, 79, 81, 83, 85], a number of high quality 
longitudinal investigations found that either there was no relationship, or that higher distances had a protective 
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effect [25, 28, 30, 32, 35, 43, 88, 90].  Accordingly, there is no compelling evidence to support whether higher 
or lower absolute running distances affect RRI risk.  
3.4.2 Duration 
Eight studies examined duration, which was expressed as either a discrete unit increase (i.e. per session or per 
week 1.0/10.0min or 1.0hr, respectively), cumulative hours per week of running, or as a minute per session 
comparison [22, 32, 35, 36, 49, 50, 52, 71, 88] (ESM Table S5).  The median methodological quality score for 
these studies was 75.0% (range: 50.0% to 91.6%) with five studies scoring ≥75.0% [32, 35, 36, 49, 88].  Four 
studies found statistically significant associations indicating that higher running durations increased the risk of 
RRI [35, 49, 50, 71].   
The study by Hespanhol Junior et al [35] found that increasing the duration of running by 10 minutes per 
session marginally increased the risk of general RRI.  The cross-sectional study by Chang et al [71] provided 
both moderate and strong evidence that 30-60min vs. <30min, and >60 vs. <30min per session significantly 
increased the risk of foot injuries, respectively.  Conversely, the same study found that a higher duration per 
session (>60min vs. <30min) strongly decreased the risk of hip injuries [71].  In contrast, a moderate decreased 
risk of patellofemoral pain syndrome was found for females who ran a lower cumulative weekly duration (5.0hr 
(reference) <5.0hr) [50].  The other prospective and retrospective cohort studies found weak evidence that an 
increased running duration of 10.0min per session and a higher number of weight bearing physical activity hours 
per week significantly increased the risk of general RRI [35, 49].  A number of studies found no statistically 
significant relationships between RRI and duration [32, 36, 50, 52, 71, 88], and so conclusions remain open to 
speculation for this modifiable exposure. 
3.4.3 Frequency 
Fifteen studies assessed whether frequency of running training and/or competitive practice affected the risk of 
RRI [23, 24, 35, 36, 42, 43, 49, 52, 66, 67, 69, 72, 75, 88] (ESM Table S6).  The median methodological quality 
score for the eight longitudinal study designs, including one RCT, was 79.2% (range: 58.3% to 91.6%).  The 
case-control and cross-sectional designs (n=7) had a median quality score of 54.5% (range: 27.2% to 72.7%).  
Six studies found statistically significant results [24, 42, 43, 67, 69, 85].   
14 
 
A higher frequency significantly increased the risk of general RRI, and injuries to the front thigh in two 
prospective cohort studies [24, 43].  The same effect direction was found in three cross-sectional studies [67, 69, 
85].  Conversely, a lower frequency (1.0 vs. >1.0d/wk) strongly increased the risk of injury in a prospective 
cohort study of satisfactory methodological quality [42].  The study by Walter et al [24] provides evidence that 
an incremental addition of one weekly running session strongly increases the risk of RRI for males.  In the same 
study, however, only the 7.0d/wk category for females significantly increased the risk.  A number of high 
quality prospective cohort studies found no statistically significant relationships for frequency [23, 35, 36, 49, 
88].  Accordingly, it is not possible to definitively conclude that running frequency is an important factor in 
injury causation. 
3.4.4 Pace and interval 
Twenty studies were included in the pace and interval sub-category (ESM Table S7).  The median 
methodological quality score was 68.1% (range: 27.2% to 91.6%) with eight studies scoring ≥75.0% [24, 29, 30, 
35, 36, 49, 61, 88].  A total of eight studies found statistically significant differences in injured and non-injured 
groups [29, 35, 49, 61, 63, 69, 77, 84, 96].   
The high quality prospective study by Hespanhol Junior et al [35] found that a 1.0d/wk increase of speed 
training moderately increased the risk of RRI.  The same authors found that increasing interval-based training by 
1.0d/wk had a moderate protective effect.  In the prospective cohort studies by Malisoux et al [36] and Theisen 
et al [88], mean running speed (per 1.0kph unit increase) was statistically insignificant in unadjusted analyses.  
Many other studies did not find that pace and/or interval-based training affected general or specific RRI risk [24, 
30, 52, 53, 60, 66, 72, 73, 81, 83].  Based on the contrasting results and limited evidence available for the effect 
of running pace and interval training on RRI risk, it was not possible to form any definitive conclusions for 
these exposures.   
3.4.5 Weight 
Twenty-three studies examined whether body weight affected RRI risk (ESM Table S8).  Even though the 
majority of articles were cross-sectional in nature (n=14), there were eight prospective cohort investigations 
with a median quality score of 54.1% (range: 33.3% to 91.6%) [25, 29, 32, 45-48, 50].  Across the latter studies, 
only two studies found statistically significant associations between weight and injuries to the foot and plantar 
fascia [29, 50].  The significant findings in two other cross-sectional studies offered contrasting effect 
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directions, and should be subject to careful interpretation [73, 76].  In total, four studies found statistically 
significant varied effect directions or differences between groups.  There is inadequate evidence to support that 
either higher or lower body weight significantly influences RRI risk.            
3.4.6 Body mass index 
The assessment of BMI featured in 25 studies, which had a median methodological quality score of 75.0% 
(range: 33.3% to 91.6%) (ESM Table S9).  The mean quality score for the prospective cohort studies was 
69.9%, with 10 being of high quality [23, 25, 26, 31-33, 36-38, 61].  There were nine studies that found a 
statistically significant difference between BMI values between injured and non-injured runners, of which two 
reported a strong effect size [42, 50].   
In terms of specific results, there was a fivefold greater risk of spinal injuries and a 2.4 fold increased risk of 
tibial stress fracture in female runners with a BMI of <21kg/m2 compared to a 21.0kg/m2 reference [50].  
Likewise, a BMI of >26kg/m2 strongly decreased the risk of RRI in a prospective investigation of satisfactory 
quality [42].  These were unique observations, as most investigations found that a higher BMI increased RRI, 
including an RCT and prospective cohort study which both used a 1kg/m2 per unit increase exposure [31, 88].  A 
higher BMI significantly increased the risk of general and specific injures in five more prospective cohort 
investigations [31, 37, 38, 41, 61].  Given that 17 investigations did not find a statistically significant effect for 
BMI, of which 10 were longitudinal by design, it does not seem that either a higher or lower BMI is an 
important exposure in a given RRI causal mechanism.   
3.4.7 Diet and hormonal 
There were nine studies that had examined factors related to dietary practice and medication use [25, 43, 52, 55, 
56, 66, 70, 74, 89] (ESM Table 10).  The median methodological quality score for these studies was 63.6% 
(range: 50.0% to 91.6%) with an RCT [89] and prospective cohort [25] study scoring 75.0% and 91.6%, 
respectively.  Regarding dietary practices, the prospective investigation by Kelsey et al [25] found that low 
calcium intake increased the risk of stress fracture in female runners, albeit this association was not statistically 
significant.  Likewise, the case-control study by Myburgh et al [52] found a statistically significant difference in 
daily calcium intake and dairy product consumption between runners afflicted with and without stress fracture in 
crude analyses.  In the same study, no other macro and micronutrients and vitamins discriminated injured from 
non-injured runners [52].   
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In terms of medication use, the use of oral contraceptives (OCs) was associated with a decreased risk of stress 
fracture development in female distance runners across a number of studies [25, 52, 56, 66, 89].  In the RCT by 
Cobb et al [89], only the treatment-received (i.e. per protocol) analyses for ≥1 month’s continued OC use 
produced a strong statistically significant reduction in risk by 77%.  The intention-to-treat analysis in the same 
study resulted in 43% reduction in risk, albeit this was not statistically significant.  Likewise, the high quality 
prospective cohort study by Kelsey et al [25] found a strong, albeit insignificant, 2.2 fold increased risk of stress 
fracture incidence associated with reporting never having used OCs.   
The five studies that assessed the effects of menstruation on stress fracture development indicated that irregular 
or absent menstruation was associated with an increased risk [25, 52, 55, 56, 66].  In the only prospective study 
to examine menarche and menstrual patterns, a younger age at menarche (per 1.0yr unit decrease) nearly 
doubled the risk of stress fracture.  Even though no statistically significant relationship was found for a history 
of menstrual irregularity over a lifetime recall in the same study, the greater than threefold risk increase is 
clinically interesting [25].  A case-control [52] and two cross-sectional studies [56, 66] found that a significantly 
higher proportion of injured runners had irregular or absent menstrual cycles.  Overall, there is a paucity of 
literature which has examined diet and hormonal exposures as they relate to the development of RRI.  Even so, 
the evidence provided here supports a protective effect of OC use on stress fracture development, whereas 
absent or irregular menstrual patterns increased the risk.  
3.4.8 Footwear, insoles, and orthotics 
Fifteen studies examined exposures relating to footwear, insoles and orthotics (ESM Table S11).  The median 
quality score for these studies was 66.6% (range: 50.0% to 91.6%).  The use of shoe insoles and orthoses was 
strongly associated with an increased risk of developing any given RRI in four cross-sectional studies, however 
the temporality of causal effects remain subject to informed judgement [61, 63, 67, 71].  Wearing running shoes 
for longer before discarding them was associated with a decreased risk of general injury and anterior knee pain 
[61, 73].  The high quality prospective cohort study by Kluitenberg et al [38] suggested that footwear condition, 
whether used or new, does not significantly affect the risk of RRI.  The same study also found similar effects for 
footwear that was <3.0 months old compared to footwear aged between 3.0-12.0 months [38].  Wearing soft 
insoles and rotating running footwear both produced a moderate decrease in risk for knee and general injury, 
respectively [36, 71].   
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Three RCTs with a mean quality score of 69.4% (range: 50.0% to 91.6%) investigated whether different foot 
and/or running shoe types could predict the incidence and/or severity of RRI [88, 92, 93].  One RCT found that 
wearing motion control footwear in both neutral and pronated foot types significantly increased self-reported 
pain scores in female runners when compared to both stability and neutral footwear [93].  Another RCT found 
that compared to non-compliant midsoles, cushioned midsoles did not significantly reduce the incidence of RRI 
[88].  The third RCT found that both the part and full minimalist footwear conditions strongly increased the RRI 
incidence rate per 1000hrs when compared to a conventional neutral trainer [92].  The diversity of questions and 
trialled footwear types and conditions suggests that more research needs to be conducted for this particular 
modifiable sub-category. 
3.4.9 Terrain and surface 
Nineteen studies assessed whether topographic features and the compliancy of particular surfaces affected RRI 
risk (ESM Table S12).  The median quality score for the seven longitudinal investigations was 91.6% (range: 
66.6% to 91.6%), whereas the case-control and 11 cross-sectional studies scored 54.5% (range: 18.1% to 
81.8%).  One high quality prospective cohort investigation found that running 2/3rds of the time on non-
compliant surfaces, such as concrete, significantly increased the risk of general injury for female runners, but 
not males [23].  In agreement, the study by Wen et al [61] found that a lower time spent running on concrete 
decreased the risk of thigh and back injuries.  Despite being of high quality, this study used a cross-sectional 
design, and so the temporality of this effect is unknown.  Given the number of studies that found no statistically 
significant association for terrain and/or surface, including a number of high quality prospective cohort 
investigations [24, 25, 35, 36, 42], the evidence does not support that these modifiable training-related factors 
affect RRI risk. 
3.4.10 Stretching, warm-up, and cool-down 
Limited data were available for stretching, warm-up and cool-down practices [24, 30, 34, 49, 69, 73, 76, 83, 94] 
(ESM Table S13).  The median methodological quality score for the nine studies was 63.6% (range 27.2% to 
91.6%), of which the median score for five longitudinal investigations was 83.3% (range: 41.6% to 91.6%) [24, 
30, 34, 49, 94].  The cross-sectional studies that assessed the frequency and duration of stretching generally 
found that a higher proportion of injured runners stretched [69, 73, 83].  The only RCT in this sub-category, 
which tested the effect of an individualised program involving stretching, warm-up and cool-down practices, 
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found no statistically significant difference in the RRI incidence rate per 1000hrs between its two groups [94].  
Two prospective cohort studies found no statistically significant association between warming-up and cooling-
down, and general RRI [30, 34].  The high quality prospective cohort study by Walter et al [24] found a 
significant 60% increased risk associated with ‘always stretching’, versus ‘sometimes stretching’ for male 
runners, but not females.  According to the varied effect directions, it is not possible to determine whether 
stretching, warm-up, and cool-down practices increase or decrease the risk of RRI. 
3.4.11 Psychological factors 
There were 11 studies in the psychological sub-category (ESM Table S14).  The median methodological quality 
score for these studies was 69.6% (range: 36.3% to 91.6%).  There were six prospective cohort [24, 26, 31, 35, 
40, 41] and five cross-sectional studies [59, 62, 63, 76, 79].  In total, eight studies found a significant 
relationship between personality type and RRI risk [24, 26, 31, 40, 59, 62, 63, 79], with type A opposed to type 
B-related personality generally increasing the risk.  When compared to a type B personality disposition, type A 
persons are generally more competitive, outgoing, ambitious, impatient, and aggressive.  Even so, many studies 
only reported proxy variables that tenuously suggest personality type, such as training only to be competitive 
rather than running only for fitness or recreational purposes [24, 59, 63, 79].  One early cross-sectional study 
used a distinctive personality inventory, and so it was not fully understood how particular items such as being 
less ‘forthright’ and less ‘toughminded’ had affected the differences in risk between injured and non-injured 
runners [76].  A number of equivocal relationships emerged across sexes and between items in another cross-
sectional study [59].  Specifically, Ekenman et al [59] found that a higher sense of impatience, time urgency, 
and conviction to exercise significantly discriminated females afflicted with tibial stress fracture versus healthy 
controls.  Two prospective cohort investigations have since found that either there is no relationship between 
personality type and RRI [31], or that type B actually increases the risk [26].  On the whole, few scientific 
investigations have examined whether personality characteristics and/or behavioural patterns affect the risk of 
RRI.  Because of this, no definitive conclusions can be drawn.     
3.4.12 Other modifiable factors 
The other modifiable sub-category included investigations that had examined the effect of preconditioning and 
custom training plans on RRI risk, as well as exposures relating to strength training and running 
discipline/events (ESM Table S15).  Across 13 studies, the median methodological quality score was 66.6% 
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(range: 27.2% to 91.6%).  One RCT found that for competition-related injuries, an individualised injury 
prevention running program significantly decreased the RRI incidence rate per 1000hrs [95].  In the same trial, 
however, no statistically significant difference was found for the training-related injury incidence rate per 
1000hrs.  Another RCT examined the effects of a preconditioning program that aimed to facilitate gradual 
musculoskeletal adaptation prior to a running program [91].  The preconditioning intervention did not 
significantly differentiate the RRI incidence rate per 1000hrs between injured and non-injured runners [91].  A 
retrospective cohort study found a moderate decrease in injury risk for female runners if they engaged in weight 
training on two days per week, but no significant relationship was found for males [49].  A strong increased risk 
of competition-related injury in female runners was strongly associated with group-based training, rather than 
running solo [62].  The risk of sustaining a training-related injury was also moderately increased for the group-
based training condition, although this association was not statistically significant [62].  The use of specific 
conditioning programs was not protective against the development of RRI in the two RCTs that examined this.  
Further research is required to determine whether strength-based resistance training protects against injury in the 
distance running context directly.
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Table 4 Overview of select modifiable results across 12 exposure sub-categories.  The total number of studies within each sub-category, the outcome, study design and 
median quality assessment score are presented 
Exposure Total no. of 
studies (N) 
Focus on general (n)/specific (n) 
injury 
Reported study designs (n) Median (range) quality 
score 
Distance 36 17/19 RCT, 2; PC, 12; RC, 2; CC, 2; CS 19 63.6 (18.1-91.6) 
Duration 8 4/4 RCT, 1; PC, 3; RC, 2; CC, 1; CS, 1 75.0 (50.0-91.6) 
Frequency 15 10/5 RCT, 1; PC, 6; RC, 1; CC, 1; CS, 6 72.7 (27.2-91.6) 
Pace/interval 20 10/10 RCT, 1; PC, 5; RC, 1; CC, 2; CS, 11 68.1 (27.2-91.6) 
Weight 23 5/18 PC, 8; CC, 1; CS, 14 54.5 (27.2-91.6) 
BMI 25 13/12 RCT, 1; PC, 16; RC, 2; CS, 6 75 (33.3 to 91.6) 
Diet and hormonal 9 2/7 RCT, 1; PC, 2; CC, 1; CS, 5 63.6 (50.0-91.6) 
Footwear/insoles/orthotics 15 8/7 RCT, 3; PC, 3; CC, 1; CS, 8 66.6 (50.0-91.6) 
Terrain/surface 19 9/10 RCT, 1; PC, 6; CC, 1; CS, 11 65.1 (18.1-91.6) 
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Stretching/warm-up/cool-down 9 8/1 RCT, 1; PC, 3; RC, 1; CS, 4 63.6 (27.2-91.6) 
Psychological 11 10/1 PC, 6; CS, 5 69.6 (36.3-91.6) 
Other modifiable 13 11/2 RCT, 3; PC, 3; RC, 1; CS, 6 66.6 (27.2-91.6) 
BMI, body mass index; CC, case-control; CS, cross-sectional; PC, prospective cohort; RC, retrospective cohort; RCT, randomised controlled trial 
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3.5 Non-modifiable risk and protective factors 
In the non-modifiable category, there were seven sub-categories comprising individual factors identified in the 
retrieved literature: (i) age; (ii) sex; (iii) height; (iv) experience; (v) previous injury; (vi) biomedical; and; (vii) 
other non-modifiable (i.e. factors that could not be appropriately sub-categorised) (Table 5).   
3.5.1 Age 
Thirty-four studies reported the effects of age on RRI risk (ESM Table S16).  The median quality score for these 
studies was 60.8% (range: 27.2% to 91.6%) with three investigations scoring 91.6% [25, 26, 88].  Thirteen of 15 
prospective cohort studies received scores of ≥50.0% [25, 26, 29, 31-33, 36, 38, 41-43, 45, 46].  Two 
retrospective cohort studies scored 83.3% [49] and 50.0% [50], and 11 of 16 cross-sectional designs were of 
satisfactory methodological quality [57, 58, 61-63, 66, 68, 70, 72, 74, 77].  In total, nine studies reported a 
statistically significant association with age [25, 38, 41-43, 49, 50, 68, 80].  In five of nine, the direction of the 
effect between age and general RRI was inconsistent, and was further modified by sex [38, 41, 42, 49, 68].   
In terms of specific injury, a strong increased risk of front thigh injury was found for the age bracket 30-34yrs 
versus <25yrs, but not for ages either side of this (≤29yrs or ≥35yrs) [43].  Conversely, being aged 30-34yrs and 
≥40yrs strongly decreased the risk of calf injury, but no statistically significant association was found for ≤29yrs 
and 35-39yrs [43].  The study by Taunton et al [42] found a strong decreased risk of new injury, but only for 
female runners who were aged <31yrs.  A high quality prospective cohort investigation found that a younger age 
(per 1.0yr unit decrease) moderately increased the risk of stress fracture in female runners by 42.0% [25].  
Conversely, Kluitenberg et al [38] found weak evidence to support that a higher age increased the risk of general 
injury in multivariable survival analyses.  Other high quality longitudinal investigations did not find a 
statistically significant relationship between age and general or specific RRIs [26, 29, 31-33, 36], including an 
RCT after multivariable adjustment [88].  Taken as a whole, there is little scientific evidence to support that age 
is an important factor for RRI development.    
3.5.2 Sex 
Sixteen directly compared the risk of RRI across sexes (ESM Table S17).  The median quality score for these 
studies was 66.0% (range: 41.6% to 91.6%), with five studies scoring ≥75.0% [26, 32, 36, 38, 88].  The majority 
of studies, including those of a higher quality, did not find statistically significant differences in RRI risk across 
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sex.  The multivariable adjusted analysis in the prospective cohort study by Buist and colleagues [41] found a 
moderately significant increased risk of general injury among males when compared to females.  Another study, 
albeit cross-sectional by design, also found that male runners aged <40yrs had a moderately significant higher 
odds of sustaining a given injury when compared to their female counterparts [67].  In contrast, Lopes et al [75] 
found that the presence of pain was significantly greater in females than males.  Similarly, females were at a 
strong increased risk of hip injuries, but not injuries to the hamstring or calf [43].  Many studies did not support 
a sex based risk difference hypothesis [26, 32, 36, 38, 39, 44, 46, 47, 65, 69, 77, 88].  On balance, there is little 
evidence to support any conceivable sex-based risk difference hypothesis. 
3.5.3 Height 
Height was examined in 20 investigations comprising seven prospective cohort studies, one retrospective cohort 
study, and 12 cross-sectional study designs (ESM Table S18).  The median quality score for these studies was 
54.0% (range: 27.2% to 91.6%).  Five investigations found statistically significant associations with height [24, 
50, 73, 76, 77], with two utilising multivariable analyses [24, 50].  The measures of association in one study 
were particularly strong, indicating that both male and female runners of <157cm in height had a significantly 
increased risk of sustaining injuries to the plantar fascia and anterior aspect of the knee when compared to a 
157cm reference group, respectively [50].  No relationships were found for a number of other specific injuries.  
According to these data, and given the absence of statistically significant differences in 15 studies, the evidence 
to support height as a risk factor is very weak. 
3.5.4 Experience  
Thirty-eight studies examined whether factors related to running experience affected the risk of RRI (ESM 
Table S19).  Across 16 longitudinal study designs, including one RCT, the median methodological quality score 
was 79.1% (range: 50.0% to 91.6%).  The median quality for the two case-control and 20 cross-sectional studies 
was 54.5% (range: 27.2% to 81.8%).  Measures used in the studies ranged from absolute or cumulative monthly 
or yearly units of running to other historical measures, such as years of axial loading and years engaged in 
competitive running.  The high quality prospective cohort study by Buist et al [31] found that a history of non-
axial loading doubled the risk of injury in males, but not females.  The opposite picture emerged in another 
prospective cohort study whereby a history of non-axial loading strongly increased the risk of injury in females, 
but not males [41].  One high quality RCT found no significant evidence to support the association between 
24 
 
experience, or the number of weekly competitions, and RRI, but it did find a strong protective effect associated 
with reporting having run regularly in the prior 12 months [88].  Conversely, running year round was shown to 
strongly increase the risk of general RRI in another prospective cohort study for both males and females [24].  A 
number of investigations with varied study designs found higher training and/or competition-related experience 
to be associated with an significantly increased risk of general and specific RRI [29, 49, 66, 69, 72, 75, 84, 85], 
but this was not the common rule [23, 31, 38, 41, 43, 50, 61, 62, 65, 77].  Consideration of the overall evidence 
and the number of studies that found no statistical relationship suggests that running experience does not affect 
the development of RRI. 
3.5.5 Previous injury 
A total of 22 studies examined the association between previous injury and the development of a subsequent 
RRI (ESM Table S20).  There was one RCT [88], 15 prospective cohort studies [23-26, 29, 31, 32, 34-36, 38, 
39, 41, 44], two retrospective cohort studies [49, 50], and four cross-sectional studies [62-65] in this sub-
category.  The median methodological quality scores for these studies was 78.4% (range: 50.0% to 91.6%).  
Overall, only three investigations failed to find statistically significant effects for previous injury [34, 41, 50].  
The measures of association for the remaining 19 studies were universally strong and statistically significant.  
Based on this evidence, previous injury is a strong risk factor for RRI development. 
3.5.6 Biomedical factors 
Six studies tested the association between select biomedical factors and RRI [25, 32, 43, 52, 74, 80] (ESM Table 
S21).  The median methodological quality score for these studies was 56.4% (range: 36.3% to 91.6%).  There 
were three prospective cohort studies [25, 32, 43], one case-control study [52], and two cross-sectional studies 
[74, 80].  In the high quality prospective cohort study by Kelsey et al [25], a lower whole-body bone mineral 
content (BMC) strongly increased the risk of stress fracture in female runners.  In corroboration, the case-
control study by Myburgh et al [52] found runners with stress fracture had a significantly lower bone mineral 
density (BMD) in a number of anatomical locations when compared to healthy controls.  Conversely, the cross-
sectional study by Grimston et al [80] found that females without stress fracture had significantly lower BMD 
values in the lumbar spine and femoral neck compared to runners with stress fracture.  A later cross-sectional 
study found no statistically significant differences in BMD values between injured and non-injured female 
runners with tibial stress fracture across a range of bodily locations [74].  In the only histopathological 
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investigation, a significantly strong increased risk of Achilles tendinopathy development in the presence of 
higher intratendinous microvascular networks was found [32].  More studies are required to investigate 
biomedical exposures as they relate specifically to their effect on RRI risk. 
3.5.7 Other non-modifiable factors 
Other non-modifiable factors were related to demographic characteristics (ESM Table S22).  There were five 
studies in this sub-category with a median methodological quality score of 63.6% (range: 36.3% to 83.3%).  In 
the high quality prospective cohort study by Van Middelkoop et al [30], a high level of education decreased the 
risk of RRI, albeit the effect was weak and non-significant.  Fitness level, number of children, marital status, 
occupation and income in a number of cross-sectional studies also did not dictate injury status [66, 69, 70, 79].
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Table 5 Overview of select non-modifiable results across seven exposure sub-categories.  The total number of studies within each sub-category, the outcome, study design 
and median quality assessment score are presented 
Exposure Total no. of studies 
(N) 
Focus on general (n)/specific (n) 
injury 
Reported study designs (n) Median (range) quality score 
Age 34 15/19 RCT, 1; PC, 15; RC, 2; CS, 16 60.8 (27.2-91.6) 
Sex 16 9/7 RCT, 1; PC, 9; CS, 6 66.0 (41.6-91.6) 
Height 20 5/15 PC, 7; RC, 1; CS, 12 54.0 (27.2-91.6) 
Experience 38 17/21 RCT, 1; PC, 13; RC, 2; CC, 2; CS, 20 65.1 (27.2-91.6) 
Previous injury 22 12/10 RCT, 1; PC, 15; RC, 2; CS, 4 78.4 (50.0-91.6) 
Biomedical 6 0/6 PC, 3; CC, 1; CS, 2 56.4 (36.3-91.6) 
Other non-modifiable 5 5/0 PC, 1; CS, 4 63.6 (36.3-83.3) 
CC, case-control; CS, cross-sectional; PC, prospective cohort; RC, retrospective cohort; RCT, randomised controlled trial 
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4.0 Discussion 
The purpose of this systematic review was to compile the evidence about modifiable and non-modifiable 
training-related and behavioural risk and protective factors on the risk of developing middle- and long-distance 
RRI.  This is important because knowledge about whether or not the modification of certain factors will reduce 
the risk of RRI is valuable information for a number of persons and organisations, including but not limited to, 
runners, coaches, academic researchers, community-based healthcare professionals, and athletic governing 
bodies.   
In terms of methodological quality, the mean score associated with the reviewed RCTs was satisfactory 
(63.5%).  The PEDro scale mainly showed that a number of included RCTs did not meet criteria for blinding 
with regard to intervention allocation.  However, it is not always ethically or practically possible to blind 
participants, therapists, and/or research staff to sports medicine interventions, and so this finding is not 
unexpected.  Regarding the cohort studies, the mean quality score was satisfactory (72.8%), albeit the ratings of 
the observational follow-up period received a low overall score because few studies were more than 12 months 
in duration.  Among the cross-sectional and case-control study designs, 58.3% did not report the recall period 
for injury history and/or training-related practices, and even fewer studies reported a clear definition of injury 
(28.%).  Contrastingly, 84% of longitudinal study designs clearly defined the study’s outcome.  Despite this 
discrepancy, a detailed and discernible injury definition was still reported in only a limited number of 
retrospective studies that aimed to determine the risk factors for a specific injury selected and diagnosed a 
priori.  For example, certain cross-sectional and case-control studies used their injury definition to identify 
runners who had experienced comparable impairments to training-related practices, but only because they 
shared the same pathological features of a suspected injury e.g. [73, 77, 81].  This took place prior to a formal 
diagnostic procedure to confirm either inclusion or exclusion.  Therefore, irrespective of study design, future 
investigations should clearly state and operationalise the consensus-based standardised definition for reporting a 
RRI event [97]. 
Regarding the compiled evidence on modifiable factors, limited evidence suggested that irregular or absent 
menstruation, and never having used OCs, were associated with an increased risk of stress fracture development 
[25, 52, 55, 56, 66, 89].  Because these two factors are related to the female athlete triad, more research is now 
required to clarify how precisely hormone imbalances (as displayed by menstrual irregularities), along with 
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other factors, affect the risk of stress fracture development in female distance runners.  Varied effect directions 
and/or a number of statistically insignificant results for a given exposure were found for distance, duration, 
frequency, pace and intervals, weight, BMI, footwear, insoles and orthotics, terrain and surface, stretching, 
warm-up and cool-down practices, psychology, and individualised training programs.  Regarding non-
modifiable factors, varied effect directions and/or a number of statistically insignificant results for a given 
exposure were found for age, sex, height, experience, and certain exposures in the biomedical sub-category such 
as BMD and BMC.  The only factor that consistently increased the risk of RRI was reporting a history of 
previous injury [4, 5, 8, 9, 11, 13, 15].   
Saragiotto et al [15] have described how runners might adopt different biomechanical patterns when running in 
response to an existing or previous pain stimulus.  In particular, runners will attempt to protect themselves from 
further physical harm or re-injury by modifying their running gait cycle.  Whilst previous injury is not 
modifiable itself, it might be possible to influence outcomes associated with injury history such as through 
improved rehabilitation programs.  Therefore, the next step for research is to further investigate why and how 
previous injury contributes to the development of subsequent injury [8, 15].  This enhanced information would 
provide clinical staff and physical therapists with additional knowledge about how to protect previously injured 
runners from sustaining a subsequent injury, be it via physical screening or tailoring training-related advice 
accordingly (e.g. instructing about the risk of rapidly increasing weekly running distances).  Given that previous 
injury is a non-modifiable, runner-intrinsic factor, its effect on increasing subsequent injury risk necessitates 
both clinical expertise and high quality epidemiological data.  It is essential to recognise that repeat, recurrent, 
and multiple injuries are not synonymous, and because of this, the subsequent injury categorisation (SIC) model 
should now be used to inform and guide the design of future RRI epidemiological investigations [98].   
Contrary to the conclusions offered in previous reviews [4, 5, 9-11], we did not find adequate evidence to 
support that a higher weekly running distance increased the risk of RRI.  Indeed, the term ‘higher’ is entirely 
relative to the individual runner and his/her underlying physiology [99, 100].  Accordingly, Nielsen et al [13] 
identified that a complex relationship involving distance, frequency, duration and pace, has not been sufficiently 
accounted for, whether methodologically or analytically, in the majority of studies to date.  For example, even 
though it has been traditional practice to quantify running distance as a time-fixed exposure, it is more accurate 
to examine how distance changes over time in relation to injury risk [8, 28, 37, 90, 101].  The only two 
investigations to compare differences in running distance progression were both statistically insignificant yet 
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clinically interesting [28, 90].  Specifically, the mean survival time for runners randomised to a 10% graded 
program over a 13 week period was 212 minutes compared to 167 minutes for runners left to their own devices 
over an 8 week period [90].  Likewise, novice runners who increased their weekly distance by more than 30% 
over a fortnightly period were at a 60% increased risk of sustaining a RRI when compared to a group who 
increased their distance by less than 10% [28].  Based on these results, future research should aim to determine 
how much running the musculoskeletal system can tolerate given the presence of other pertinent time-dependent 
exposures.  Theoretically, this means hypotheses should formally prioritise running participation in relation to 
other time-varying factors.  From an analytical standpoint, this requires adoption of time-to-event statistical 
analyses which better account for the dynamic nature of risk [102].  Recent interest and new developments 
surrounding the relationship between rapidly increasing training loads and injury should now be extended to the 
distance RRI context [103].   
A limited number of studies examined diet and hormonal factors.  The available evidence was insufficient to 
support whether or not overall energy intake, macro and micronutrients, or general medication use were 
associated with RRI.  On the other hand, despite few studies of varied design, OC use was found to be 
associated with a decreased risk of stress fracture development [25, 52, 56, 66, 89].  Further research is now 
required to elucidate how OC use protects against stress fracture development in female athletes.  In particular, 
the need to use OCs is likely attributable to a number of specific deleterious physiological effects associated 
with the female athlete triad.  This well-known phenomenon is characterised by the tight interplay between 
amenorrhea, suboptimal energy availability, and reduced BMD [104].  Together, these factors manifest and not 
only detrimentally affect sporting performance, but also pose a serious risk to the athlete’s overall health [104, 
105].  Given that this systematic review also found that irregular or absent menstruation was associated with a 
significantly increased risk of stress fracture development [25, 52, 55, 56, 66], more research should now 
investigate how key exposures associated with the female athlete triad interact and ultimately affect the risk of 
distance RRI.  However, this could prove challenging as the feasibility of conducting experimental trials in this 
area has been questioned [89].   
Whether a product of intuition or due to the practicalities of ascertainment and quantification, age, running 
distance, BMI, and running experience, have featured recurrently in the RRI literature (Table 4 and Table 5).  
Despite heightened interest surrounding these factors, conclusions pertaining to their effect on RRI development 
remain speculative at best.  This is primarily due to methodological and analytical heterogeneity, including the 
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way in which exposures have been quantified and measured, the sampling of varied populations, different 
lengths of follow-up, and the use of a range of injury definitions and statistical techniques.  The results from this 
systematic review do not reflect the first-hand experiences of recreational distance runners about what factors 
they personally believe cause RRI [106].  Further qualitative studies are now required to confirm whether or not 
there is a wider disconnect between the evidence generated via highly controlled epidemiological inquiry, and 
runners’ opinions and beliefs about RRI causation [107].  Likewise, more research utilising a longitudinal study 
design needs to investigate the effect of personality type, behavioural patterns, and motivation on the risk of RRI 
development [26, 31].  The same line of reasoning applies to the paucity of literature that has examined different 
dietary practices and regimes of nutritional supplementation [52].  In terms of exposures relating to preparatory 
practices and athletic recovery, this systematic review was limited in scope given that it could only identify few 
studies reporting the effects of warm-up, cool-down and/or stretching routines in relation to injury susceptibility.  
Therefore, future RRI prevention research should both increase its depth and widen its breadth in terms of 
refining existing knowledge and exploring new topics.  It is now time to investigate new research areas and 
introduce novel hypotheses in the RRI context. 
4.1 Limitations 
A number of limitations in this review should be noted.  Starting with the search strategy itself, there is a 
possibility that potentially eligible articles were not retrieved, particularly given that one author independently 
examined the eligibility of identified articles during the first round screening process.  However, when the 
decision to include an article was not clear, consultation with another author occurred.  In terms of the inclusion 
criteria, the direction of a causal effect between a given exposure and RRI cannot be directly ascertained when 
using case-control and cross-sectional study designs.  Even though a strength of such study designs lies with 
their ability to collect and analyse a multitude of exposures simultaneously, their inclusion in this review does 
mean that some lower quality evidence was included.  In a similar way, results would have greater external 
validity if risk and protective factors were identified for specific injury types so as to avoid the over- and under-
representation of certain exposures [15].  However, summarising the factors for a specific injury is not currently 
possible because of the shortage of original research.  Similarly, caution should be exercised when making 
comparisons across studies given the use of varying injury definitions and diverse population samples.  
Regarding data extraction and their interpretation, the diversity of the included articles meant that it was not 
feasible to obtain a common pooled estimate across similar studies in which to perform a meta-analysis.  
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Therefore, the interpretation of association measures was based on whether or not an exposure was statistically 
significant according to the confidence interval.  Clinical significance was considered where possible, but many 
studies simply did not report measures of association when their results were not statistically significant.  
Regarding the methodological quality assessment, if a given study did not disclose which exposures were 
adjusted for in the analyses, yet stated that multivariable model was used, the corresponding item was scored 
positive.  It might have been better to appraise a given study according to whether or not the statistical model 
accounted for important covariates to enhance the interpretation of results. 
5.0 Conclusions  
This systematic review found that a history of previous injury was associated with an increased risk of both 
general and specific RRI.  Determining precisely why and how previous injury increases the risk of subsequent 
injury now requires the use of existing epidemiological concepts such as the SIC model to inform and guide the 
design of future RRI investigations [98].  In terms of modifiable exposures, irregular or absent menstruation, 
and never having used OCs, were associated with an increased risk of stress fracture development.  More 
research should now investigate how key exposures associated with the female athlete triad interact and 
ultimately affect the risk of distance RRI.  The quality of the reviewed studies means that no definitive 
conclusions were able to be made for the other modifiable and non-modifiable factors in terms of their 
relationship to RRI.  Further studies of rigorous design and conduct are needed to rule out the existence, or not, 
of such effects.
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Electronic Supplementary Material Table S2 Observational study design quality assessment checklist 
Study objective Explanation 
1. Positive – if the study had a clearly 
defined purpose [CS/CC/PC] 
 Explain the scientific background in a formal review of literature 
 Provide a rationale for the investigation and report the purpose 
 Where suitable, include a priori expectations, predictions/hypotheses 
Study population Explanation 
2. Positive – if the setting, locations, and 
relevant dates, including periods of 
recruitment are described [CS/CC/PC] 
 If recruiting runners from a racing event, include the location, date and how long recruitment spanned 
 Indicate where (geographic area) the runners were recruited from 
3. Positive – if the main demographic and 
training-related features of the study 
population are described [CS/CC/PC] 
 External validity is compromised if no details are provided for this item 
 Details should include past and/or current training-related history/habits (e.g. average distance per week, usual 
pace/intensity of training and/or racing, frequency of running per week, predominant running surfaces, experience or 
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years running, number of races in previous year etc.) 
 Tabularisation of these descriptive data preferred but not required for approval (this item is subject to some 
interpretation, that is, enough detail has to be reported to appreciate the characteristics of the sample in which to 
generalise findings) 
 One of the earliest examples to score positive for this item is Macera et al’s (1989) study which provided the 
minimum required detail in order to comprehend the population 
4. Positive – if the eligibility criteria and 
sampling methods/strategy for selecting 
participants are reported [CS/CC/PC] 
 Provide eligibility criteria and the sources and methods of selecting participants (e.g. ‘runners aged between 18 and 
65 years who were running at least three times per week were approached in their usual training grounds/athletic 
clubs and provided with a questionnaire’, or, ‘questionnaires were included in every marathon entrants’ race pack and 
distributed on one of three days before the start of the event’) 
 Regarding comparative trials or case-control studies: (i) how long have injured/cases been symptomatic; (ii) what 
was the rationale for selecting cases; (iii) has there been a satisfactory description of the clinical examination in 
which to establish a diagnosis; (iv) what measures were taken to rule out differential diagnoses; (v) how were non-
injured/controls selected and recruited; (vi) for matched studies, give matching criteria and number of non-
injured/controls per case 
5. Positive – if numbers at each stage of the 
study are reported [CS/PC] 
 Potentially eligible, examined for eligibility, confirmed eligible, included, and analysed 
 It might not always be possible to report numbers included, but an attempt must be made to report the numbers 
enrolled and analysed 
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 A flow diagram is desirable but is not required for approval 
 This item applies to enrolment for prospective cohort studies 
6. Positive – if the participation rate at the 
main moment of follow-up is at least 80% 
for observation periods of ≤6 months, or at 
least 60% for observation periods of ≥7 
months [PC] 
 The longer the follow-up period, the greater the probability that participants will drop-out of the study 
Outcome measurements Explanation 
7. Positive – if the methods used to collect 
data are reported [CS/CC/PC] 
 Include information on self-administered questionnaires  
 It is enough to report that ‘a questionnaire was used to obtain training-related habits’, but ideally, justification for the 
questionnaire or satisfactory detail of solicited information should be provided 
 Whether or not the questionnaire has been pilot tested and the number of questionnaire items/modifications to 
existing instruments is desired but is not required for approval 
 For case-control studies, or where a physical examination is reported (i.e. in certain cases for cohorts and cross-
sectional studies), indicate the exact clinical examination procedures used (for purposes of replication in subsequent 
studies), and, ideally, disclose the experience/qualification of clinicians (latter desired but not required for approval) 
8. Positive – if the prospective observational 
period was ≥12 months [PC] 
 Injury risk will vary according to seasonal cycles 
 Even in the case of amateur runners who might not adhere to a training program, seasonal variation in terms of 
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weather patterns and calendar dates might affect injury patterns 
9. Positive – if the retrospective recall 
period is reported [CS/CC] 
 Study designs with a retrospective focus (CS/CC) should report participants’ recall period pertaining to their training-
related history/habits or injury history (i.e. is the training-related information derived over a lifetime recall, current 
practice, or the previous three months, and, have participants reported any injuries sustained over their running career 
or only in the previous year etc.) 
10. Positive - if the injury definition and 
self-reported physical impairment concepts 
are reported [CS/CC/PC]  
 Injury definitions such as, for example, ‘an injury had to interfere with the ability to run’ are ambiguous and do not 
indicate if runners were involuntarily incapacitated (time-loss), or, they were compromised to a degree (i.e. forced 
involuntary reduction or modification of distance and/or pace etc.) 
 The consequences of the injury that resulted in a diagnosis (symptoms associated with injury), rather than only 
reporting the injury assessment itself (signs), is to be scored positive, even for clinical retrospective investigations 
 An appropriate definition would be: ‘a running-related injury was defined as complete involuntary cessation of 
running (i.e. forced time-loss) due to musculoskeletal pain directly attributable to distance running’ 
 Physical impairments include: pain, and/or restriction/modification, and/or time-loss, and/or medical intervention 
Analysis and data presentation Explanation 
11. Positive – if the analysis/physical 
assessment is reported to have occurred 
under blinded conditions [CS/CC/PC] 
 Analysts are to be blinded when working with data regarding group allocation (e.g. anonymous data, or a mention of 
a third party analyst) 
 It is desirable to have two analysts independently follow the same procedural statistical technique 
 Where a retrospective physical exam is performed, practitioners should not know injury status 
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 For a fair and objective analysis, statistical analysts should not know the coding details for injury status when 
working with statistical software 
12. Positive – if the statistical analyses and 
methods used are transparently reported 
[CS/CC/PC] 
 The statistical package and version used (desired but not required for approval) 
 Specific statistical analyses used 
 Separate statistical methods section at the end of methods (preferred but not required for approval) 
13. Positive – if analyses adequately 
adjusted for confounders whether individual 
factors (e.g. age, sex, BMI, previous injury) 
and/or training-related (e.g. volume, pace) 
[CS/CC/PC] 
 Studies will be scored positive if there is indication that potential confounders were adjusted in a multivariate 
regression model  
 Adjusted measures of association are reported 
 Ideally, justification should be given for why certain confounders were included and adjusted for (not required for 
approval) 
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Electronic Supplementary Material Table S3 PEDro quality assessment checklist for randomised controlled trials 
1. Eligibility criteria were specified 
2. Subjects were randomly allocated to groups (in a crossover study, subjects were randomly allocated an order in which treatments were received) 
3. Allocation was concealed 
4. The groups were similar at baseline regarding the most important prognostic indicators 
5. There was blinding of all subjects 
6. There was blinding of all therapists who administered the therapy 
7. There was blinding of all assessors who measured at least one key outcome 
8. Measures of at least one key outcome were obtained from more than 85% of the subjects initially allocated to groups 
9. All subjects for whom outcome measures were available received the treatment or control condition as allocated or, where this was not the case, data for at least one key 
outcome was analyzed by “intention to treat” 
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10. The results of between-group statistical comparisons are reported for at least one key outcome 
11. The study provides both point measures and measures of variability for at least one key outcome 
12. Self-reported physical impairment concepts are reported a 
Injury definitions such as, for example, ‘an injury had to interfere with the ability to run’ are ambiguous and do not indica te if runners were incapacitated (time-loss), or, they 
were compromised to a degree (i.e. forced involuntary reduction of volume or pace etc.). The consequences of the injury that resulted in a diagnosis (symptoms associated 
with injury), rather than only reporting the injury assessment itself (signs), is to be scored positive e.g. ‘A running-related injury was defined as complete involuntary 
cessation of running (i.e. forced time-loss) due to musculoskeletal pain directly attributable to distance running’. Physical impairments include: pain, and/or 
restriction/modification, and/or time-loss, and/or medical intervention 
a PEDro expanded with single item 
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Electronic Supplementary Material Table S4 Extracted information on running-related injury studies that had considered distance as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation 
Theisen et al 
(2013) 
RCT 91.6 General Per 1.0km ↑ - - 
Buist et al (2008) RCT 75.0 General Standard vs. graded (10%) running program 
(20.8% IIP vs. 20.3% IIP) 
OR = 0.6; 95% CI: 0.6-1.3; p = 
0.90 
- 
    212min to injury vs. 167min to injury (45min 
diff.) 
- - 
Kelsey et al (2007) PC 91.6 SFX Mean dist. p/w past 12mo (per 10.0km ↑) (♀) HR = 1.08; 95% CI: 0.81-1.45 (†) - 
Macera et al (1989) PC 91.6 General 0-15.8 (ref) 16.0-31.8km (♂) - - 
    0-15.8 (ref) 32.0-47.8km (♂) - - 
    0-15.8 (ref) 48.0-63.8km (♂) - - 
    0-15.8 (ref) >64.0km (♂) OR = 2.9; 95% CI: 1.1-7.5 (†) Higher dist. ↑ risk 
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    0-15.8 (ref) 16.0-31.8km (♀) - - 
    0-15.8 (ref) 32.0-47.8km (♀) - - 
    0-15.8 (ref) 48.0-63.8km (♀) - - 
    0-15.8 (ref) >64.0km (♀) - - 
Nielsen et al 
(2014b) 
PC 91.6 Multiple varied 
injuries 
% change in wk dist. (<10% (ref) 10%-30%) HR = 1.03; 95% CI: 0.37-2.90; p 
= 0.96 
- 
    % change in wk dist. (<10% (ref) >30%) HR = 1.59; 95% CI: 0.96-2.66; p 
= 0.07 
- 
Walter et al (1989) PC 91.6 General <16.0 (ref) 16.0-31.8km (♂) - - 
    <16.0 (ref) 32.0-46.4km (♂) - - 
    <16.0 (ref) 48.0-62.4km (♂) - - 
    <16.0 (ref) >64.0km (♂) RR = 2.22; 95% CI: 1.30-3.68 (†) Higher dist. ↑ risk 
    <16.0 (ref) 16.0-31.8km (♀) - - 
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    <16.0 (ref) 32.0-46.4km (♀) - - 
    <16.0 (ref) 48.0-62.4km (♀) - - 
    <16.0 (ref) >64.0km (♀) RR = 3.42; 95% CI: 1.42-7.85 (†) Higher dist. ↑ risk 
    Longest run per wk >8km (y vs. n) (♂) RR = 2.49; 95% CI: 1.64-3.71 (†) Long run >8km ↑ 
risk  
    Longest run per wk >8km (y vs. n) (♀) RR = 1.78; 95% CI: 0.99-3.13) 
(†) 
- 
Hirschmüller et al 
(2012) 
PC 83.3 AT 56.8 vs. 54.3km - - 
Van Middelkoop et 
al (2008) 
PC 83.3 General Long dist. training (always) OR = 0.76: 95% CI: 0.54-1.07; p 
= 0.12 (†) 
- 
Wen et al (1997) PC 81.8 Hamstring -  OR = 1.11; p = 0.005 (†) Higher dist. ↑ risk 
Hespanhol Junior 
et al (2013) 
PC 75.0 General Per 1.0km ↑ OR = 1.00; 95% CI: 0.99-1.01; p 
= 0.920 
- 
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Malisoux et al 
(2013) 
PC 75.0 General  Mean session distance (per 1.0km ↑) HR = 0.79; 95% CI: 0.73-0.87 (†) Higher dist. ↓ risk 
Reinking et al 
(2007) 
PC 58.3 ERLP <64.0 (ref) ≥64.0km RR = 1.44; 95% CI: 0.79-2.62 - 
    ≥64.0 (ref) <64.0km RR = 0.69; 95% CI: 0.38-1.27 - 
Satterthwaite et al 
(1999) 
PC 58.3 Hamstring Per 10.0km ↑ OR = 1.07; 95% CI: 1.02-1.13; p 
<0.008 (†) 
Higher dist. ↑ risk 
   Knee Per 10.0km ↓ OR = 1.13; 95% CI: 1.04-1.23; p 
<0.003 (†) 
Lower dist. ↑ risk  
Hootman et al 
(2002) 
RC 83.3 General <32.0 vs. >32.0km - - 
Warren & Davis RC 41.6 Multiple varied 
injuries 
- - - 
Myburgh et al 
(1990) 
CC 50.0 SFX 53.0 vs. 45.0km - - 
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Miller et al (2007) CC 40.0 ITBFS 38.1 vs. 19.0km p = 0.06 - 
Lloyd et al (1986) CS 2 
group 
72.7 General 10.1 vs. 8.7km (timeframe not reported) (♀) p <0.001 Inj. had a higher 
dist. 
Marti et al (1988b) CS 2 
group 
72.7 General 26.3 vs. 22.0km P <0.001 - 
McKean et al 
(2006) 
CS 2 
group 
72.7 Multiple varied 
injuries 
- - - 
Rasmussen et al 
(2013) 
CS 2 
group 
72.7 General 30.0-60.0 (ref) 0.0-30.0km RR = 2.02; 95% CI: 1.26-3.24; p 
<0.01 (†) 
Lower dist. ↑ risk 
    30.0-60.0 (ref) >60.0km RR = 1.13; 95% CI: 0.45-2.79; p 
= 0.80 (†) 
- 
    Longest dist. 6wk prior to marathon (>30.0 
(ref) 25.0-30.0km) 
RR = 1.18; 95% CI: 0.68-2.08; p 
= 0.55  
- 
    Longest dist. 6wk prior to marathon (>30.0 
(ref) <25.0km) 
RR = 1.27; 95% CI: 0.71-2.26; p 
= 0.42  
- 
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Gerlach et al 
(2005) 
CS 2 
group 
63.6 Multiple varied 
injuries 
- - - 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General >~48.3km (~67.0% inj. vs. 48.0%) 
(histogram)  
p <0.001 Higher % of inj. 
higher dist.  
Bennell et al 
(2004) 
CS 2 
group 
54.5 TSFX 54.2 vs. 48.8km (♀) p = 0.39 - 
Duffey et al (2000) CS 2 
group 
54.5 AKP 40.5 vs. 42.6km - - 
Haglund-Åkerlind 
et al (1993) 
CS 2 
group 
54.5 AT 106.0 vs. 85.8km p <0.05 Inj. had a higher 
dist. 
Messier et al  
(1995) 
CS 2 
group 
54.5 ITBFS 50.3 vs. 42.5km p = 0.01 Inj. had a higher 
dist. 
Valliant (1981) CS 2 
group 
54.5 General 76.4 vs. 47.6km p <0.01 Inj. had a higher 
dist. 
Grimston et al CS 2 36.3 SFX 60.7 vs. 57.4km (♀) - - 
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(1991) group 
Marti & Rehmann 
(1987) 
CS 2 
group 
36.3 General Habitual dist. wk (values not reported)  SRC 0.57; p = .000 (†) Higher dist. ↑ risk  
Messier et al  
(1991) 
CS 2 
group 
36.3 PFPS 33.7 vs. 48.8km t = 2.82; p <0.008 Inj. had a higher 
dist. 
McCrory et al 
(1999) 
CS 2 
group 
27.2 AT 52.1 vs. 44.5km - - 
McQuade (1986) CS 2 
group 
27.2 General 32.1 vs. 24.1km t = 2.44, p <0.02 Inj. had a higher 
dist. 
Messier & Pittala 
(1988) 
CS 3 
group 
27.2 General Control = 48km; MTSS = 39km; ITBFS = 
46km; PF = 52km 
- - 
Knobloch et al 
(2008) 
CS 2 
group 
27.2 Back >65.0km (ref not reported) OR = 2.3; 95% CI: 1.13-4.65; p = 
0.019  
Higher dist. ↑ risk  
Caselli & 
Longobardi (1997) 
CS 2 
group 
18.1 General -  r2 = .92 (histogram)   Inj. had a lower 
dist.  
xxiii 
 
AT, Achilles tendinopathy; AKP, anterior knee pain; CI, confidence interval; CC, case-control; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-
sectional three group comparison; ERLP, exercise-related leg pain; HR, hazard ratio; IIP, injury incidence proportion; ITBFS, iliotibial band friction syndrome; MTSS, 
medial tibial stress syndrome; OR, odds ratio; PC, prospective cohort; PFPS, patellofemoral pain syndrome; RC, retrospective cohort; RCT, randomised controlled trial; RR, 
relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), 
methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S5 Extracted information on running-related injury studies that had considered duration as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation 
Theisen et al (2013) RCT 91.6 General Per session (per 1.0min ↑) HR = 0.99; p = 0.34 - 
    Per wk (per 1.0hr ↑) - - 
Hirschmüller et al 
(2012) 
PC 83.3 AT Per wk (3.6 vs. 3.4hr) - - 
Hespanhol Junior et 
al (2013) 
PC 75.0 General Per session (per 10.0min ↑) OR = 1.01; 95% CI: 1.00-1.02; p = 
0.008 (†) 
Higher duration ↑ 
risk  
Malisoux et al 
(2013) 
PC 75.0 General Per session (per 1.0min ↑) - - 
Hootman et al 
(2002) 
RC 83.3 General Weight baring PA/wk (hr); values not 
reported (♂) 
OR = 1.11; 95% CI: 1.06-1.17; p = 
0.0001 (†) 
Higher duration ↑ 
risk 
    Weight baring PA/wk (hr); values not 
reported (♀) 
- - 
xxv 
 
Taunton et al (2002) RC 50.0 Multiple varied 
injuries 
Per wk (5.0 (ref) <5.0hr) (♂) - - 
   PFPS Per wk (5.0 (ref) <5.0hr) (♀) OR = 0.54; 95% CI: 0.34-0.84 (†) Lower duration ↓ 
risk  
   Multiple varied 
injuries 
Per wk (5.0 (ref) <5.0hr) (♀) - - 
Myburgh et al 
(1990) 
CC 50.0 SFX Per wk (6.0 vs. 5.0hr) - - 
Chang et al (2012) CS 2 
group  
63.6 Hip Per session (30-60 vs. <30min) OR = 1.10; 95% CI: 0.38-3.16; p = 
0.860 (†) 
- 
    Per session (>60 vs. <30min) OR = 0.34; 95% CI: 0.13-0.86; p = 
0.020 (†) 
Higher duration ↓ 
risk 
   Foot Per session (30-60 vs. <30min) OR = 1.43; 95% CI: 0.73-2.83; p = 
0.300 (†) 
- 
    Per session (>60 vs. <30min) OR = 3.04; 95% CI: 1.47-6.28; p = Higher duration ↑ 
xxvi 
 
0.003 (†) risk  
AT, Achilles tendinopathy; CC, case-control; CI, confidence interval; CS 2 group, cross-sectional two group comparison; HR, hazard ratio; OR, odds ratio; PC, prospective 
cohort; PFPS, patellofemoral pain syndrome; RC, retrospective cohort; RCT, randomised controlled trial; RR, relative risk; SFX, stress fracture; (-) not reported/statistically 
significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality)  
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Electronic Supplementary Material Table S6 Extracted information on running-related injury studies that had considered frequency as an exposure 
 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation 
Theisen et al 
(2013) 
RCT  91.6 General Per 1.0d/wk ↑ - - 
Macera et al 
(1989) 
PC 91.6 General 6.0 or 7.0d/wk (comparator not reported) 
(♂) 
OR = 1.4; 95% CI: 0.8-2.5 (†) - 
    6.0 or 7.0d/wk (comparator not reported) 
(♀) 
OR = 0.5; 95% CI: 0.1-2.1 (†) - 
Walter et al 
(1989) 
PC 91.6 General 0.0-2.0d (ref) 3.0d/wk (♂) RR = 2.93; 95% CI: 1.27-6.20 (†) Higher freq. ↑ 
risk 
    0.0-2.0 (ref) 4.0d/wk (♂) RR = 2.49; 95% CI: 1.08-5.26 (†) Higher freq. ↑ 
risk 
    0.0-2.0 (ref) 5.0d/wk (♂) RR = 3.13; 95% CI: 1.38-6.46 (†) Higher freq. ↑ 
risk 
    0.0-2.0 (ref) 6.0d/wk (♂) RR = 3.66: 95% CI: 1.62-7.50 (†) Higher freq. ↑ 
risk 
xxviii 
 
    0.0-2.0 (ref) 7.0d/wk (♂) RR = 5.92; 95% CI: 2.49-12.75 (†) Higher freq. ↑ 
risk 
    0.0-2.0d (ref) 3.0d/wk (♀) - - 
    0.0-2.0 (ref) 4.0d/wk (♀) - - 
    0.0-2.0 (ref) 5.0d/wk (♀) - - 
    0.0-2.0 (ref) 6.0d/wk (♀) - - 
    0.0-2.0 (ref) 7.0d/wk (♀) RR = 5.50; 95% CI: 1.44-17.39 (†) Higher freq. ↑ 
risk 
Hespanhol Junior 
et al (2013) 
PC 75.0 General Per 1.0d/wk ↑ OR = 1.01; 95% CI: 0.87-1.18; p = 
0.856  
- 
Malisoux et al 
(2013) 
PC 75.0 General  Per 1.0d/wk ↑ - - 
Taunton et al 
(2003) 
PC 66.6 General overall 1.0d/wk (♀) OR = 3.65; 95% CI: 1.08-12.29 (†) Lower freq.↑ risk  
    1.0d/wk (♂) - - 
xxix 
 
    2.0d/wk - - 
    3.0d/wk - - 
    4.0d/wk - - 
    5.0d/wk  - - 
Satterthwaite et al 
(1999) 
PC 58.3 Front thigh Per 1d/wk ↑ OR = 1.19; 95% CI: 1.05-1.34; p 
<0.008 (†) 
Higher freq. ↑ 
risk 
Hootman et al 
(2002) 
RC 83.3 General <6 vs. >6d/wk - - 
Myburgh et al 
(1990) 
CC 50.0 SFX - - - 
Lloyd et al (1986) CS 2 
group 
72.7 General 5.1 vs. 4.8d/wk (♀) - - 
McKean et al 
(2006) 
CS 2 
group 
72.7 Multiple varied 
injuries 
1.0-3.0 (ref) 4.0-5.0d/wk (<40yr) OR = 1.32; 95% CI: 1.07-1.62; p = 
0.009 (†) 
Higher freq. ↑ 
risk 
    1.0-3.0 (ref) >6d/wk (<40yr) OR = 1.77; 95% CI: 1.25-2.53; p = Higher freq. ↑ 
xxx 
 
0.002 (†) risk 
    1.0-3.0 (ref) 4.0-5.0d/wk (>40yr) - - 
    1.0-3.0 (ref) >6.0d/wk (>40yr) OR = 2.24; 95% CI: 1.46-3.45; p 
<0.001 (†) 
Higher freq. ↑ 
risk 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General >5d/wk (~50% vs. ~32%) (histogram) p <0.001 Higher % inj.  
Haglund-Åkerlind 
et al (1993) 
CS 2 
group 
54.5 AT 7.9 vs. 7.0d/wk - - 
Lopes et al (2011) CS 2 
group  
54.5 General 3.0d/wk (IQR = 3.0-4.0d/wk vs. 3.0d/wk 
(IQR = 3.0-4.0d/wk) 
p = 0.793 - 
Knobloch et al 
(2008) 
CS 2 
group 
27.2 MTSS >4.0d/wk (comparator not reported) OR = 2.3; 95% CI: 1.09-4.96; p = 
0.025 
>4d/wk ↑ risk 
AT, Achilles tendinopathy; CI, confidence interval; CC, case-control; CS 2 group, cross-sectional two group comparison; IQR, interquartile range; MTSS, medial tibial stress 
syndrome; OR, odds ratio; PC, prospective cohort; RC, retrospective cohort; RCT, randomised controlled trial; RR, relative risk; SFX, stress fracture; (-) not 
reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S7 Extracted information on running-related injury studies that had considered pace and intervals as exposures 
 
Study Design Quality (%) 
(*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Theisen et al 
(2013)  
RCT  91.6 General  Per 1.0kph ↑ HR = 0.91; p = 0.29 - 
Walter et al (1989) PC 91.6 General Usual training pace (values not 
reported) 
- - 
Van Middelkoop et 
al (2008) 
PC 83.3 General Intervals (always) OR = 0.76: 95% CI: 0.54-1.07; 
p = 0.12 (†) 
- 
Wen et al (1998) PC 83.3 Shin % time intervals (inj./weeks 
accumulated) 
RIIR = 14.89; 95% CI: 0.50-
147.32; p <0.05 (†) 
Interval ↑ risk 
Hespanhol Junior 
et al (2013) 
PC 75.0 General  Speed training (per 1.0d/wk ↑) OR = 1.46; 95% CI: 1.02-2.10; 
p = 0.039 (†) 
Higher freq. ↑ risk 
    Interval training (per 1.0d/wk ↑) OR = 0.61; 95% CI: 0.43-0.88; Higher freq. ↓ risk 
xxxii 
 
p = 0.008 (†) 
Malisoux et al 
(2013) 
PC 75.0 General Per 1.0kph ↑ HR = 0.95; p = 0.48 - 
Hootman et al 
(2002) 
RC 83.3 General Prior 12.0mo (<9:20 (ref) 
>9:20min/km) (♂) 
OR = 0.51; 95% CI: 0.35-0.74; 
p = <0.001 (†) 
Lower pace ↓ risk  
    Prior 12.0mo (<9:20 (ref) 
>9:20min/km) (♀) 
- - 
Myburgh et al 
(1990) 
CC 50.0 SFX “Intensity” (values not reported) - - 
Miller et al (2007) CC 40.0 ITBFS 5km time (23.4 vs. 22.9min) p = .84 - 
Wen et al (1997) CS 2 group 81.8 Shin % time intervals (0 vs. 1-10 vs. >20) OR = 55.91; p = 0.04 (†) Inj. Performed more 
interval-based training 
Lloyd et al (1986) CS 2 group 72.7 General 5:12 vs. 4:48min/km - - 
Marti et al (1988b) CS 2 group 72.7 General 16km time (1:11:01 vs. 1:11:32) p <0.05 Inj. had a higher pace 
xxxiii 
 
Jacobs & Berson 
(1986) 
CS 2 group 63.6 General <4:54min/km (~55% vs. ~45%) 
(histogram) 
p <0.05 Higher % of inj. had a 
higher pace 
    Interval sessions (values not reported) - - 
    Sprint training (values not reported) - - 
Duffey et al (2000) CS 2 group 54.5 AKP 4:58 vs. 4:58min/km - - 
Haglund-Åkerlind 
et al (1993) 
CS 2 group 54.5 AT Intervals (12.3 vs. 10.2km) - - 
Messier et al  
(1991) 
CS 2 group 54.5 PFPS 5:05 vs. 4:38min/km - - 
Messier et al 
(1995) 
CS 2 group  54.5 ITBFS 4:54 vs. 5:05min/km p = 0.05 Inj. had a higher pace 
McQuade (1986) CS 2 group 27.2 General 4:48 vs. 4:48min/km - - 
Messier & Pittala 
(1988) 
CS 3 group 27.2 MTSS, 
ITBFS, PF 
Control = 4:27; MTSS = 4:28; ITBFS 
= 4:06; PF = 4:21min/km 
- - 
xxxiv 
 
McCrory et al 
(1999) 
CS 2 group 27.2 AT 4:38 vs. 4:52min/km p <0.05 Inj. had a higher pace 
AT, Achilles tendinopathy; CI, confidence interval; CC, case-control; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-sectional three group 
comparison; ITBFS, iliotibial band friction syndrome; MTSS, medial tibial stress syndrome; OR, odds ratio; PC, prospective cohort; PF, plantar fasciitis; RC, retrospective 
cohort; RCT, randomised controlled trial; RR, relative risk; SFX, stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, 
decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S8 Extracted information on running-related injury studies that had considered weight as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. 
first) 
Estimate, 95% CI, and p-value Interpretation 
Kelsey et al (2007) PC 91.6 SFX Per 1.0kg ↓ (♀) HR = 1.08; 95% CI: 0.99-1.16 (†) - 
Hirschmüller et al 
(2012) 
PC 83.3 AT 73.2 vs. 70.9kg - - 
Wen et al (1998) PC 83.3 Foot Inj./weeks accumulated 
(values not reported) 
RIIR = 0.94; 95% CI: 0.89-0.99; p 
<0.05 (†) 
Heavier ↓ risk 
Thijs et al (2011) PC 58.3 PFPS 70.1 vs. 68.3kg p = 0.50 - 
Van Ginckel et al 
(2009) 
PC  50.0 General  69.8 vs. 69.9kg p = 0.971 - 
Ghani Zadah Hesar 
et al (2009) 
PC 41.6 General 73.1 vs. 69.6kg OR = 1.35; p = 0.15 - 
Taunton et al 
(2002) 
PC 41.6 Multiple varied 
injuries 
60.0 (ref) <60.0kg (♂) - - 
xxxvi 
 
   PF 60.0 (ref) <60kg (♀) OR = 0.38; 95% CI: 0.20-0.70 (†) Lighter ↓ risk  
   Multiple varied 
injuries 
60.0 (ref) <60kg (♀) - - 
Thijs et al (2008) PC 33.3 PFPS 69.3 vs. 69.3kg p = 0.98 - 
Myburgh et al 
(1990) 
CC 50.0 SFX 59.0 vs. 59.0kg - - 
Wen et al (1997) CS 2 group 81.8 Multiple varied 
injuries 
- - - 
Lloyd et al (1986) CS 2 group 72.7 General 55.9 vs. 56.4kg - - 
Marti (1988a) CS 2 group 72.7 General - - - 
Gerlach et al 
(2005) 
CS 2 group 63.6 Multiple varied 
injuries 
- - - 
Bennell et al 
(2004) 
CS 2 group 54.5 TSFX 63.6 vs. 60.4kg (♀) p = 0.25 - 
xxxvii 
 
Duffey et al (2000) CS 2 group 54.5 AKP 69.5 vs. 70.2kg p = 0.05 Inj. were lighter 
Haglund-Åkerlind 
et al (1993) 
CS 2 group 54.5 AT 69.7 vs. 68.0kg - - 
Messier et al 
(1995) 
CS 2 group  54.5 ITBFS 66.4 vs. 70.2kg - - 
Niemuth et al 
(2005) 
CS 2 group 54.5 Multiple varied 
injuries 
- - - 
Ribeiro et al 
(2011a) 
CS 3 group 54.5 PF Current = 78.0; history = 
75.4kg; no = 71.9kg 
p = 0.24 - 
    Current = 57.8; history = 62.0; 
no = 55.8kg 
p = 0.58 - 
Ribeiro et al 
(2011b) 
CS 3 group 54.5 PF Current = 69.6; history = 72.3; 
no 66.8kg  
p = 0.58 - 
Valliant (1981) CS 2 group 54.5 General 71.1 vs. 58.1kg p <0.001 Inj. were heavier 
Grimston et al CS 2 group 36.3 SFX 55.5 vs. 53.1kg - - 
xxxviii 
 
(1991) 
McCrory et al 
(1999) 
CS 2 group 27.2 AT 71.4 vs. 70.03kg - - 
AKP, anterior knee pain; AT, Achilles tendinopathy; CC, case-control; CI, confidence interval; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-
sectional three group comparison; HR, hazard ratio; ITBFS, iliotibial band friction syndrome; OR, odds ratio; PC, prospective cohort; PF, planter fasciitis; PFPS, 
patellofemoral pain syndrome; RIIR, relative injury incidence rate; RR, relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-), not reported/statistically 
significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S9 Extracted information on running-related injury studies that had considered body mass index as an exposure 
Study Design Quality 
(%) (*) 
Injury type Descriptor (comparator (inj. 
group first) 
Estimate, 95% CI, and p-value Interpretation  
Theisen et al 
(2013) 
RCT 91.6 General Per 1.0kg/m2 ↑ HR = 1.13; 95% CI: 1.03-1.23 (†) Higher BMI ↑ 
risk 
Macera et al 
(1989) 
PC 91.6 General 26th-74th (ref) <26th percentile (♂) OR = 1.2; 95% CI: 0.7-1.9 (†) - 
    26th-74th (ref) >74th percentile (♂) OR = 0.7; 95% CI: 0.5-1.2 (†) - 
    26th-74th (ref) <26th percentile (♀) OR = 2.0; 95% CI: 0.6-6.6 (†) - 
    26th-74th (ref) >74th percentile (♀) OR = 3.0; 95% CI: 0.5-18.8 (†) - 
Kelsey et al 
(2007) 
PC 91.6 SFX Per 1.0kg/m2 ↓ (♀) HR = 1.20; 95% CI: 0.90-1.61 (†) - 
Nielsen et al 
(2013b) 
PC 91.6 General  20.0-25.0 (ref) <20.0kg/m2 cIRD at 500km; 14.1%; 95% CI: -
31.6%-3.5%; p = 0.12  
- 
xl 
 
    20.0-25.0 (ref) 25.0-30.0kg/m2 cIRD at 500km; 2.7%; 95% CI: -10.2%-
15.7%; p = 0.68  
- 
    20.0-25.0 (ref) >30.0kg/m2 cIRD at 500km; 10.3%; 95% CI: -3.7%-
24.3%; p = 0.15  
- 
Nielsen et al 
(2014a) 
PC 91.6 General  <30.0 (ref) >30.0kg/m2 (≤3.0km 1st 
week) 
-  - 
    <30.0 (ref) >30.0kg/m2 (3.0-6.0km 
1st week) 
cIRD = 14.3%; 95% CI: 3.3%-25.3%; p 
= 0.01 
Higher BMI ↑ 
risk 
    <30.0 (ref) >30.0kg/m2 (>6.0km 1st 
week) 
cIRD = 16.2%; 95% CI: 4.4%-28.0%; p 
<0.01 
Higher BMI ↑ 
risk 
Bredeweg et al 
(2013) 
PC 83.3 General 24.4 vs. 24.7kg/m2 (♂) - - 
    24.3 vs. 23.3kg/m2 (♀) - - 
Buist et al 
(2010b) 
PC 83.3 General Per 1.0kg/m2 ↑ (♂) HR = 1.14; 95% CI: 1.05-1.25 (†) Higher BMI ↑ 
risk 
    Per 1.0kg/m2 ↑ (♀) - - 
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Hirschmüller et 
al (2012) 
PC 83.3 AT 23.6 vs. 22.9kg/m2  - 
Wen et al 
(1997) 
PC 81.8 Heel High vs. low (tertiles not reported) OR = 1.24; p = 0.005 (†) Higher BMI ↑ 
risk 
Malisoux et al 
(2013) 
PC 75.0 General Per 1.0kg/m2 ↑  HR = 1.03; p = 0.510 (†) - 
Kluitenberg et 
al (2015) 
PC 75.0 General Per 1.0kg/m2 ↑ HR = 1.04; 95% CI: 1.00-1.07; p = 
0.034 (†) 
Higher BMI ↑ 
risk 
Bennett et al 
(2012) 
PC 66.6 In-season ERLP 18.5-24.9 (ref) <18.5kg/m2 OR = 2.4; 95% CI: 0.5-11.1 - 
   In-season medial ERLP 18.5-24.9 (ref) <18.5kg/m2 OR = 1.6; 95% CI: 0.3-9.0 - 
Buist et al 
(2010a) 
PC 66.6 General Per 1.0kg/m2 ↑ (♂) HR = 1.02; 95% CI: 0.94-1.11; p = 0.58 
(†) 
- 
    Per 1.0kg/m2 ↑ (♀) HR = 1.06; 95% CI: 1.01-1.13; p = 
0.028 (†) 
Higher BMI ↑ 
risk 
xlii 
 
Taunton et al 
(2003) 
PC 66.6 General <21.0kg/m2  - - 
    21.0-24.0kg/m2 - - 
    24.0-26.0kg/m2 - - 
    >26.0kg/m2 (♂) OR = 0.41; 95% CI: 0.21-0.79 (†) Higher BMI ↓ 
risk  
    <21.0kg/m2  - - 
    21.0-24.0kg/m2 - - 
    24.0-26.0kg/m2 - - 
    >26.0kg/m2 (♀) - - 
Thijs et al 
(2011) 
PC 58.3 PFPS 25.4 vs. 24.4kg/m2 p = 0.20 - 
Van Ginckel et 
al (2009) 
PC 50.0 AT 24.9 vs. 24.7kg/m2 p = 0.84 - 
xliii 
 
Thijs et al 
(2008) 
PC 33.3 PFPS 24.9 vs. 25.1kg/m2 p = 0.80 - 
Hootman et al 
(2002) 
RC 83.3 General Prior 12.0mo (<25.0 (ref) 
>25.0kg/m2) 
- - 
Taunton et al 
(2002) 
RC  50.0 Multiple varied injuries 21.0 (ref) <21.0kg/m2 (♂) - - 
   TSFX 21.0 (ref) <21.0kg/m2 (♀) OR = 2.43; 95% CI: 0.99-5.94 (†) - 
   Spinal 21.0 (ref) <21.0kg/m2 (♀) OR = 4.98; 95% CI: 1.36-18.27 (†) Lower BMI ↑ 
risk 
   Multiple varied injuries 21.0 (ref) <21.0kg/m2 (♀) - - 
Parker et al 
(2011) 
CS 2 
group 
81.8 General training-related ≥25.0 (ref) <18.5kg/m2 (♀) OR = 1.71; 95% CI: 0.37-7.80; p = 0.49 
(†) 
- 
    ≥25.0 (ref) 18.5-24.9kg/m2 (♀) OR = 1.13; 95% CI: 0.61-2.07; p = 0.71 
(†) 
- 
    ≥25.0 (ref) <18.5kg/m2 (♀) OR = 2.30; 95% CI: 0.32-16.38; p = - 
xliv 
 
0.41 (†) 
    ≥25.0 (ref) 18.5-24.9kg/m2 (♀) OR = 1.44; 95% CI: 0.59-3.52; p = 0.42 
(†) 
- 
Rasmussen et al 
(2013) 
CS 2 
group 
72.7 General >25.0 vs. <25.0kg/m2 RR = 0.88; 95% CI: 0.47-1.68; p = 0.70 
(†) 
- 
Gerlach et al 
(2005) 
CS 2 
group 
63.6 Multiple varied injuries - - - 
Bennell et al 
(2004) 
CS 2 
group 
54.5 TSFX 22.2 vs. 22.1kg/m2 (♀) p = 0.91 - 
Ribeiro et al 
(2011a) 
CS 3 
group 
54.5 PF Current = 25.5; history = 23.3; no = 
23.5kg/m2 (♂) 
p = 0.24 - 
    Current = 23.4; history = 22.3; no = 
21.7kg/m2 (♀) 
p = 0.30 - 
Ribeiro et al 
(2011b) 
CS 3 
group 
54.5 PF Current = 24.3; history = 23.0; no = 
22.5kg/m2 
p = 0.30 - 
xlv 
 
AT, Achilles tendinopathy; BMI, body mass index; CI, confidence interval; cIRD, cumulative injury risk difference; CS 2 group, cross-sectional two group comparison; CS 3 
group, cross-sectional three group comparison; ERLP, exercise-related leg pain; HR, hazard ratio; OR, odds ratio; PC, prospective cohort; PFPS, patellofemoral pain 
syndrome; RC, retrospective cohort; RCT, randomised controlled trial; RR, relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically 
significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S10 Extracted information on running-related injury studies that had considered diet and hormonal exposures  
 
Study Design Quality 
(%) (*) 
Injury 
type 
Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Cobb et al (2007) RCT 75.0 SFX OC use (y vs. n) (♀) HR = 0.57; 95% CI: 0.18-
1.83 (†) 
- 
    OC use ≥1 month continued use (y vs. n) 
(♀) 
HR = 0.23; 95% CI: 0.06-
0.86 (‡) (†)  
OC use ↓ risk  
    OC use ≥3 months continued use (y vs. n) 
(♀) 
HR = 0.42; 95% CI: 0.11-
1.57 (‡) (†) 
- 
Kelsey et al (2007) PC 91.6 SFX Daily dietary calcium intake (per 100mg ↓) 
(♀) 
HR = 1.11; 95% CI: 0.98-
1.25 (†) 
- 
    Never used OCs (♀) HR = 2.22; 95% CI: 0.65-
7.69 (†) 
- 
    Total eating disorder inventory score (per HR = 1.03; 95% CI: 0.86, - 
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5 units) (♀) 1.24 (†) 
    Menarche (per 1.0yr ↓) (♀) HR = 1.92; 95% CI: 1.15-
3.23 (†) 
Younger age at menarche ↑ risk  
    % body fat (per 5.0% ↓) (♀) HR = 1.16; 95% CI: 0.71-
1.89 (†) 
- 
    History of menstrual irregularity (<9p/yr) 
(♀) 
HR = 1.90; 95% CI: 0.66-
5.51 (†) 
- 
    Menstrual irregularity in past year (< 
9p/yr) (♀) 
HR = 1.05; 95% CI: 0.38-
2.89 (†) 
- 
    History of menstrual irregularity (y vs. n) HR = 3.41; 95% CI: 0.69-
16.91 (†) 
- 
Satterthwaite et al 
(1999) 
PC 58.3 Thigh Social drinker (y vs. n)  OR = 1.38; 95% CI: 1.01-
1.88; p <0.04 (†) 
↑ risk if consumes alcohol socially 
   Knee Medication use (y vs. n) OR = 1.56; 95% CI: 1.02-
2.32 (†) 
↑ risk if reported using medication 
xlviii 
 
Myburgh et al (1990) CC 50.0 SFX OC use (y vs. n) (♀) p <0.05 Higher % of inj. never used OCs 
    Calcium (697 vs. 832mg) p = 0.02 Higher calcium consumed by non-
inj.  
    Dairy product intake (9.7 vs. 12.9 portions 
p/w) 
p <0.05 Higher # of dairy products 
consumed by non-inj. 
    Energy intake (7.0 vs. 8.0mj/d) - - 
    Protein (63 vs. 71gm/d) - - 
    Fibre (22 vs. 20gm/d) - - 
    Alcohol (15 vs. 14gm/d) - - 
    Caffeine (326 vs. 297mg/d) - - 
    Vitamin D (1.6 vs. 1.7mcg/d) - - 
    Phosphorous (1166 vs. 1186mg/d) - - 
    Current menstrual status (irregular vs. 
normal) (♀) 
p <0.005 Higher % of inj. had irregular 
menstruation  
xlix 
 
    History of menstrual irregularity & 
familial osteoporotic fractures (y vs. n) (♀) 
- - 
    Yrs of irregular menstruation (4.5 vs. 
5.0yrs) (♀) 
- - 
    Menarche (13.9 vs. 14.0yr) (♀) - - 
Lloyd et al (1986) CS 2 
group 
72.7 General  OC use (y vs. n) (♀) p <0.001 Higher % of inj. never used OCs 
    OC use (y vs. n) (♀) p <0.0001 (†) OC use ↓ risk 
    Menstrual history (regular vs. irregular or 
absent) (♀) 
p <0.025 Higher % of inj. had irregular 
menses  
    Menstrual history (regular vs. irregular or 
absent) (♀) 
p <0.029 (†) Irregular or absent menstruation ↑ 
risk  
    Menarche (12.90 vs. 12.86yr) (♀) - - 
   SFX OC use prior 24mo (never used inj. = 29% 
vs. used inj. = 12%) (♀) 
p = 0.04 Higher % of inj. never used OCs 
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Gerlach et al (2005) CS 2 
group 
63.6 General % body fat (values not reported) - - 
Henriksson et al 
(2000) 
CS 3 
group 
63.6 General Menstrual status (irregular = 34.1d 
interruption vs. regular = 9d interruption) 
(♀) 
p <0.05 Higher # interrupted days of 
running in irregular group 
Barrow & Saha (1988) CS 3 
group 
54.5 SFX Menses (regular = 29.0% vs. irregular = 
39.0% vs. abnormal = 49.0%) (♀) 
p <0.05 Higher % of irregular and abnormal 
menstruation in inj. group  
Bennell et al (2004) CS 2 
group 
54.5 TSFX Menarche (13.8 vs. 14.3yr) (♀) p = 0.35 - 
    Number of menses prior 12mo (10.2 vs. 
10.3) (♀) 
p = 0.65 - 
    Menstrual pattern (amen. = 1.1 vs. 0.3; 
oligo. = 1.1 vs. 1.1; eumen. = 13.4 vs. 
14.9yr) (♀) 
p = 0.47, p = 0.25, p = 0.58 - 
    Menstrual index (mean annual menses 
since menarche; 8.7 vs. 9.7) (♀) 
p = 0.23 - 
li 
 
    Previous OC use (11 vs. 17) (♀) p = 0.46 - 
    Duration of OC use (6.2 vs. 6.4yr) (♀) p = 0.95 - 
CI, confidence interval; CC, case-control; CS 2 group, cross-sectional two group comparison; HR, hazard ratio; OR, odds ratio; PC, prospective cohort; RCT, randomised 
controlled trial; RR, relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, 
decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S11 Extracted information on running-related injury studies that had considered footwear, insoles, and orthotics as exposures 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Theisen et al 
(2013) 
RCT  91.6 General Shoe system (hard sole (ref) soft sole) HR = 0.92; 95% CI: 0.57-
1.48; p = 0.731 (†) 
- 
Ryan et al (2014) RCT 66.6 General IIR per 1000hr (neutral = 3.56 (ref) part 
minimal = 15.83) (‡) 
RR = 3.1%; 95% CI: 1.12% 
– 8.57% 
Part minimal ↑ risk 
    IIR per 1000hr (neutral = 3.56 (ref) full 
minimal = 7.17) (‡) 
RR = 1.6%; 95% CI: 
0.52%–4.96% 
- 
    Foot and ankle disability index (neutral vs. 
part/full minimal) 
- - 
Ryan et al (2010) RCT 50.0 General (VAS 
rest) 
Neutral foot (motion control = 5.1 vs. stability 
= 1.5 vs. neutral = 0.8) (♀) 
p <0.001 Higher pain in motion 
control 
   General (VAS 
daily living) 
Neutral foot (motion control = 10.7 vs. 
stability = 2.5 vs. neutral = 4.3) (♀) 
p <0.001 Higher pain in motion 
control 
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   General (VAS 
run) 
Neutral foot (motion control = 15.3 vs. 
stability = 7.3 vs. neutral = 12.5) (♀) 
p <0.001 Higher pain in motion 
control 
   General (VAS 
rest) 
Pronated foot (motion control = 11.1 vs. 
stability = 2.9 vs. neutral = 4.1) (♀) 
p <0.001 Higher pain in motion 
control 
   General (VAS 
daily living) 
Pronated foot (motion control = 12.6 vs. 
stability = 5.7 vs. neutral = 2.9) (♀) 
p <0.001 Higher pain in motion 
control 
   General (VAS 
run) 
Pronated foot (motion control = 19.0 vs. 
stability = 11.4 vs. neutral = 5.6) (♀) 
p <0.001 Higher pain in motion 
control 
   General (VAS 
rest) 
Highly pronated (motion control vs. stability 
vs. neutral) (♀) 
- - 
   General (VAS 
daily living) 
Highly pronated (motion control vs. stability 
vs. neutral) (♀) 
- - 
   General (VAS 
run) 
Highly pronated (motion control vs. stability 
vs. neutral) (♀) 
- - 
Malisoux et al PC 75.0 General Footwear rotation (n (ref) y) HR = 0.61; 95% CI: 0.39- Shoe rotation ↓ risk  
liv 
 
(2013) 0.97 (†) 
Kluitenberg et al 
(2015) 
PC 75.0 General Shoe condition (used (ref) new) HR = 1.22; 95% CI: 0.79-
1.89; p = 0.371 (†) 
- 
    Shoe condition (used (ref) other) HR = 1.84; 95% CI: 0.96-
3.52; p = 0.064 (†) 
- 
    Shoe age (<3 (ref) 3.0-12.0mo) HR = 1.24; 95% CI: 0.80-
1.90; p = 0.337 (†) 
- 
    Shoe age (<3.0 (ref) >12.0mo) HR = 1.03; 95% CI: 0.64-
1.67; p = 0.901 (†) 
- 
Taunton et al 
(2003) 
PC 66.6 General overall 
(**) 
Shoe age (1.0-3.0mo) (♂) - - 
    Shoe age (4.0–6.0mo)  (♂) OR = 0.36; 95% CI: 0.15-
0.83 (†) 
↓ risk 
    Shoe age (7.0-12.0mo)  (♂) - - 
    Shoe age (1.0-2.0yr)  (♂) - - 
lv 
 
    Shoe age (1.0-3.0mo) (♀) - - 
    Shoe age (4.0–6.0mo) (♀) OR = 1.74; 95% CI: 1.01-
2.98 (†) 
↓ risk 
    Shoe age (7.0-12.0mo) (♀) - - 
    Shoe age (1.0-2.0yr) (♀) - - 
   General new (**) Shoe age (1.0-3.0mo) (♀) RR = 0.61; 95% CI: 0.38-
0.99 (†) 
 
Myburgh et al 
(1990)  
CC 50.0 SFX Footwear age - - 
Wen et al (1997) CS 2 
group 
81.8 General Footwear use/duration (tertiles not reported) OR = 0.93; p = 0.042 (†) Higher duration ↓ risk 
    Insole use (y vs. n) OR = 1.98; p = 0.048 (†) Insole use ↑ risk 
   Foot Insole use (y vs. n) OR = 6.85; p = 0.000 (†) Insole use ↑ risk 
   General Footwear rotation (tertiles not reported) - - 
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McKean et al 
(2006) 
CS 2 
group 
72.7 Multiple varied 
injuries 
Orthotic use; <40yr (n (ref) y)  OR = 1.91; 95% CI: 1.47-
2.49; p = 0.001 (†) 
Orthotic use ↑ risk  
    Orthotic use; >40yr (n (ref) y) OR = 1.83; 95% CI: 1.33-
2.53; p <0.001 (†) 
Orthotic use ↑ risk 
Marti (1988a) CS 2 
group 
72.7 General Footwear type (values not reported) (♀) - - 
Marti et al (1988b) CS 2 
group 
72.7 General Orthotic use (13.8% vs. 7.1%) p <0.001 Higher % inj. used 
orthotics  
    Footwear brand choice - - 
Chang et al (2012) CS 2 
group 
63.6 Knee Knee orthotics (y vs. n) OR = 2.01; 95% CI: 1.31-
3.11; p = 0.002 (†) 
Orthotic use ↑ risk 
    Soft insoles (y vs. n) OR = 0.70; 95% CI: 0.47-
0.92; p = 0.012 (†) 
Soft insole use ↓ risk 
   Hip Medial arch support (y vs. n) OR = 0.31; 95% CI: 0.11-
0.86; p = 0.025 (†) 
Medial arch support use 
↓ risk  
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   Ankle Ankle brace (y vs. n) OR = 3.49; 95% CI: 1.41-
8.63; p = 0.007 (†) 
Ankle brace use ↑ risk  
Duffey et al (2000) CS 2 
group 
54.5 AKP Footwear use (~860km vs. ~1,115km) p = 0.003 Inj. accumulated a 
lower distance in 
running footwear 
Messier et al  
(1991)  
CS 2 
group 
54.5 PFPS Footwear brand choice - - 
Messier et al 
(1995)  
CS 2 
group  
54.5 ITBFS Footwear use (900.4km vs. 1176km) - - 
AKP, anterior knee pain; CC, case-control; CI, confidence interval; CS 2 group, cross-sectional two group comparison; HR, hazard ratio; IIR, injury incidence rate; ITBFS, 
iliotibial band friction syndrome; OR, odds ratio; PC, prospective cohort; PFPS, patellofemoral pain syndrome; RCT, randomised controlled trial; RR, relative risk; SFX, 
stress fracture; VAS, visual analogue scale; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality 
score (higher numbers indicate superior quality); (‡) part minimal and full minimal represent progressively decreasing the thickness, heel height and stiffness of the midsole 
under the foot; (**) general overall and general new represent whether the participant was currently afflicted with injury or whether the injury was sustained during follow-
up; part minimal footwear refers to a medium profile that situates between a barefoot style of running and a fully cushioned shoe 
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Electronic Supplementary Material Table S12 Extracted information on running-related injury studies that had considered terrain and surface as exposures 
 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Theisen et al 
(2013) 
RCT  91.6 General % of total sessions (hard surface) HR = 1.00; p = 0.66 - 
Kelsey et al (2007) PC 91.6 SFX % distance on pavement/concrete (per 
5.0% ↓) 
HR = 1.05; 95% CI: 0.94-
1.18 (†) 
- 
Macera (1989) PC 91.6 General % time spent on concrete (1/3rd (ref) 
2/3rd) (♀) 
OR = 5.6; 95% CI: 1.1-
29.3 (†) 
Non-compliant surface ↑ risk 
    % time spent on concrete (1/3rd (ref) 
2/3rd) (♂)  
OR = 1.4; 95% CI: 0.8-2.5 
(†) 
- 
Walter et al (1989) PC 91.6 General Terrain and surface (values not 
reported) 
- - 
Hespanhol Junior PC 75.0 General Surface; dirt, grass and gravel (ref not OR = 0.89; 95% CI: 0.71- - 
lix 
 
et al (2013) reported) 1.11; p = 0.287 
    Surface; asphalt and concrete (ref not 
reported) 
OR = 1.06; 95% CI: 0.86-
1.31; p = 0.588 (†) 
- 
    Surface; sand and synthetic (ref not 
reported) 
OR = 0.25; 95% CI: 0.05-
1.25; p = 0.092 (†) 
- 
    Surface; treadmill (ref not reported) OR = 1.03; 95% CI: 0.87-
1.21; p = 0.745  
- 
    Terrain; flat (ref not reported) OR = 0.97; 95% CI: 0.81-
1.17; p = 0.773 
- 
    Terrain; uphill (ref not reported) OR = 0.53; 95% CI: 0.26-
1.08; p = 0.081  
- 
    Terrain; uphill (ref not reported) OR = 0.65; 95% CI: 0.38-
1.13; p = 0.126 (†) 
- 
    Terrain; downhill (ref not reported) OR = 0.09; 95% CI: 0.004-
2.08; p = 0.133  
- 
lx 
 
    Terrain; downhill (ref not reported) OR = 0.12; 95% CI: 0.01-
1.75; p = 0.122 (†) 
- 
Malisoux et al 
(2013) 
PC 75.0 General % of total sessions (hard surface) HR = 0.99; p = 0.48 - 
Taunton et al 
(2003) 
PC 66.6 General % of time on road, trail, grass, 
treadmill (values not reported) 
- - 
Myburgh et al 
(1990) 
CC 50.0 SFX Surface type (values not reported) - - 
Wen et al (1997) CS 2 group 81.8 Thigh % time concrete (tertiles not reported) OR = 0.05; p = 0.02 (†) Lowest time on non-compliant 
surfaces ↓ risk  
   Back % time concrete (tertiles not reported) OR = 0.19; p = 0.03 (†) Lowest time on non-compliant 
surfaces ↓ risk 
Marti (1988a) CS 2 group 72.7 General “Usual training terrain” (values not 
reported) 
- - 
Jacobs & Berson CS 2 group 63.6 General Surface type (values not reported) - - 
lxi 
 
(1986) 
Duffey et al 
(2000) 
CS 2 group 54.5 AKP % time on different surfaces (values 
not reported) 
- - 
Haglund-Åkerlind 
et al (1993) 
CS 2 group 54.5 AT Hills (0.8km vs. 0.7km) - - 
Messier et al  
(1991) 
CS 2 group 54.5 PFPS % time on different surfaces (values 
not reported) 
- - 
Messier et al 
(1995) 
CS 2 group  54.5 ITBFS % time synthetic track (5.4 vs. 1.4) p = 0.007 Inj. had a higher % training time 
on track  
    % time asphalt (75.9 vs. 74.5) - - 
    % time dirt (7.2 vs. 9.8) - - 
Knobloch et al 
(2008) 
CS 2 group 27.2 AT Asphalt (ref not reported)  OR = 0.47; 95% CI: 0.25-
0.89; p = 0.019 
Non-compliant surface ↓ risk 
    Sand (ref not reported) OR = 10; 95% CI: 1.12-
92.8; p = 0.011 
Compliant surface ↑ risk 
lxii 
 
McCrory et al 
(1999) 
CS 2 group 27.2 AT % time on different surfaces (values 
not reported) 
- - 
Messier & Pittala 
(1988) 
CS 3 group 27.2 MTSS, 
ITBFS, PF 
Crowned roads, trails and/or hills (% 
reported in histogram) 
- - 
Fonsenca et al 
(2015) 
CS 2 group 18.1 General  Treadmill vs. no treadmill (values not 
reported) 
p = 0.04 Treadmill ↓ inj. prevalence  
AKP, anterior knee pain; AT, Achilles tendinopathy; CI, confidence interval; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-sectional three group 
comparison; ERLP, HR, hazard ratio; ITBFS, iliotibial band friction syndrome; MTSS, medial tibial stress syndrome; OR, odds ratio; PC, prospective cohort; PFPS, 
patellofemoral pain syndrome; PF, plantar fasciitis; RCT, randomised controlled trial; RR, relative risk; SFX, stress fracture; (-) not reported/statistically significant; (†), 
adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S13 Extracted information on running-related injury studies that had considered stretching, warm-up, and cool-down as 
exposures 
Study Design Quality 
(%) (*) 
Injury 
type 
Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation 
Van Mechelen et al 
(1993) 
RCT 41.6 General  Stretch, warm-up & cool-down 
program (ctrl vs. int.) 
IIR = 4.9 vs. 5.5 per 1000h; 95% CI: 3.1-
7.4 vs. 95% CI: 3.6-8.0 
- 
Walter et al (1989) PC 91.6 General  Stretch (always (ref) usually) 
(♂) 
- - 
    Stretch (always (ref) sometimes) 
(♂) 
RR = 1.56; 95% CI: 1.10-2.21 (†) ↑ risk if reported stretching 
sometimes  
    Stretch (always (ref) never) (♂) - - 
    Stretch (always (ref) usually) 
(♀) 
- - 
    Stretch (always (ref) sometimes) 
(♀) 
- - 
lxiv 
 
    Stretch (always (ref) never) (♀) - - 
    Warm up practices (values not 
reported) 
- - 
Van Middelkoop et al 
(2008) 
PC 83.3 General Warm-up (always) OR = 0.79; 95% CI: 0.55-1.12; p = 0.18 
(†) 
- 
Van Middelkoop et al 
(2007) 
PC 75.0 General Cool-down (never (ref) always) OR = 0.51; 95% CI: 0.21-1.26; p = 0.14 
(†) 
- 
Hootman et al (2002) RC 83.3 General Stretch 2d/wk (y vs. n) - - 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General  Stretch prior to run (~89% vs. 
~79%) 
p <0.025 Higher % inj. stretched  
Duffey et al (2000) CS 2 
group 
54.5 AKP Stretch (7.0 vs. 5.0min) p = 0.042 On average, inj. stretched 
longer 
Valliant (1981) CS 2 
group 
54.5 General  Prior warm-up routine - - 
McQuade (1986) CS 2 27.2 General  Stretch (n (ref) y) RR = 2.0: 95% CI: 1.07-3.8, p = 0.03 Inj. stretch longer (higher % 
lxv 
 
group of non-stretchers) 
AKP, anterior knee pain; CS 2 group, cross-sectional two group comparison; IIR, injury incidence rate; OR, odds ratio; PC, prospective cohort; RC, retrospective cohort; 
RCT, randomised controlled trial; RR, relative risk; (-) = not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), 
methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S14 Extracted information on running-related injury studies that had considered psychology as an exposure 
Study Design Quality (%) 
(*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation  
Nielsen et al 
(2013b) 
PC 91.6 General TASRI (type B (ref) type A) cIRD = -11.9%; 95% CI: -23.3%--
0.5%; p = 0.04 
Type A ↓ risk  
Walter et al 
(1989) 
PC 91.6 General Competitive vs. fitness motive (♂) RR = 1.73; 95% CI: 1.21-2.49 (†) Competitive motive to 
race ↑ risk 
    Competitive vs. fitness motive (♀) - - 
Buist et al 
(2010b) 
PC 83.3 General  JAS; type A vs. type B (♂) HR = 1.02; 95% CI: 0.99-1.04 (†) - 
    JAS; type A vs. type B (♀) - - 
Hespanhol Junior 
et al (2013) 
PC 75.0 General Motivation (y (ref) neutral/impartial) OR = 1.22; 95% CI: 0.64-2.32; p = 
0.554 
- 
    Motivation (y (ref) poor) OR = 0.89; 95% CI: 0.35-2.25; p = 
0.81 
- 
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Buist et al 
(2010a) 
PC 66.6 General Motivation (competition (ref) health-
oriented) (♂) 
HR = 1.49; 95% CI: 0.84-2.66; p = 
0.17  
- 
    Motivation (competition (ref) health-
oriented) (♀) 
HR = 1.08; 95% CI: 0.70-1.67; p = 
0.73 
- 
Fields et al 
(1990) 
PC 66.6 General TASRI (>120 vs. <120au) p <0.049 Higher % inj. type A 
Parker et al 
(2011) 
CS 2 group 81.8 General 
training-related 
Self-reported; type A vs. type B (♀) OR = 2.60; 95% CI: 1.14-5.91; p = 
0.02 (†) 
Type A ↑ risk 
    Self-reported; type AB vs. type B (♀) OR = 2.78; 95% CI: 1.29-5.98; p = 
0.009 (†) 
Type AB ↑ risk 
   General 
marathon-
related  
Training satisfaction (not satisfied 
(ref) satisfied) (♀) 
OR = 1.21; 95% CI: 0.29-5.00; p = 
0.79 (†) 
- 
    Training satisfaction (not satisfied 
(ref) v. satisfied) (♀) 
OR = 0.31; 95% CI: 0.08-1.28; p = 
0.10 (†) 
- 
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Marti et al 
(1988b) 
CS 2 group 72.7 General Competitive motive (32% vs. 24.0%) p <0.001 Higher % inj. train to 
race 
Valliant (1981) CS 2 group 54.5 General Toughminded (6.03 vs. 4.53au) p <0.01 Inj. were less 
toughminded   
    Forthright (5.2 vs. 3.8au) p <0.05 Inj. were less forthright 
Ekenman et al 
(2001) 
CS 3 group 45.4 TSFX JAS-S; hard-driving/speed-
impatience (24.0 vs. 18.0au) (♀) 
p <0.02 Higher sense of 
impatience ↑ risk 
    HALTAM; time pressure (6.2 vs. 5.1) 
(♀) 
p <0.05 Higher sense of time 
urgency ↑ risk 
    CES; exercise dependency (23.0 vs. 
11.3) (♀) 
p <0.05 Higher conviction to 
exercise ↑ risk 
    HALTAM; hostility  - - 
    HALTAM; anger  - - 
    HALTAM; dominance  - - 
lxix 
 
    RIEC; locus of control  - - 
Marti & 
Rehmann (1987) 
CS 2 group 36.3 General Competitive motive (y vs. n) SRC .036; p = 0.01 (†) Competitive motive ↑ 
risk 
    Health-concerned motive (values not 
reported)  
SRC .036; p = 0.01 (†) Health-related motive ↑ 
risk 
Au, arbitrary unit, HALTAM, heart and lifestyle type A measure; CES, commitment to exercise scale; cIRD, cumulative injury rate difference; CS 2 group, cross-sectional 
two group comparison; CS 3 group, cross-sectional three group comparison; JAS-S, Jenkins activity survey Swedish modification; HR, hazard ratio; OR, odds ratio; RIEC, 
Rotter internal-external control scale; RR, relative risk; SRC, standardised regression coefficient; TARSI, type A self-reported inventory; TSFX, tibial stress fracture; (-) = 
not reported/statistically significant; (†) = adjusted measure of association; ↑ = increase; ↓ = decrease; (*), methodological quality score (higher numbers indicate superior 
quality) 
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Electronic Supplementary Material Table S15 Extracted information on running-related injury studies that had considered other modifiable factors as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Theisen et al 
(2013) 
RCT  91.6 General Mean session intensity/pace (Borg RPE) HR = 1.39; 95% CI: 1.04-1.87 
(†) 
Higher subjective 
intensities ↑ risk 
Bredeweg et al 
(2012) 
RCT 66.6 General Preconditioning program (IIP = 15.2% 
[26/171] vs. 16.8% [32/191]) 
p = 0.69 - 
    Preconditioning program (IIR = 31.0 vs. 
30.0 per 1000h) 
95% CI: 24-38 to 95% CI: 24-
37 
- 
Jakobsen et al 
(1994) 
RCT 41.6 General training-
related 
Individualised training plans (IIR = 7.4 vs. 
6.9 per 1000h) 
- - 
   General 
competition-
related 
Individualised training plans (IIR = 30.7 vs. 
62.5 per 1000h) 
p <0.005 Customised program 
↓ risk 
Van Middelkoop et 
al (2008) 
PC 83.3 General Daily smoking  OR = 0.25; 95% CI: 0.06-1.07; 
p = 0.06 (†) 
- 
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Hespanhol Junior 
et al (2013) 
PC 75.0 General Race participation during follow-up (no (ref) 
yes) 
OR = 0.79; 95% CI: 0.49-1.28; 
p = 0.33  
- 
Malisoux et al 
(2013) 
PC 75.0 General Mean session intensity/pace (Borg RPE) - - 
Hootman et al 
(2002) 
RC 83.3 General Prior 12.0mo weight training 2d/wk (y vs. n) 
(♂) 
- - 
    Prior 12.0mo weight training 2d/wk (y vs. n) 
(♀) 
OR = 0.56; 95% CI: 0.32-0.98; 
p = 0.04 (†) 
↓ risk  
Parker et al (2011) CS 2 
group 
81.8 General training-
related  
Type of training (other/solo (ref) GTP) (♀) OR = 1.38; 95% CI: 0.86-2.23; 
p = 0.18 (†) 
- 
   General 
marathon-related 
Type of training (other/solo (ref) GTP) (♀) OR = 2.36; 95% CI: 1.15-4.83; 
p = 0.02 (†) 
Group training ↑ risk 
Chang et al (2012) CS 2 
group 
63.6 Hip Race group (10km vs. 42.2km) OR = 3.02; 95% CI: 1.21-7.54; 
p = 0.02 (†) 
10km ↑ risk 
   Ankle Race group (10km vs. 42.2km) OR = 1.95; 95% CI: 1.21-3.13; 10km ↑ risk 
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p = 0.006 (†) 
    Race group (21.1km vs. 42.2km) OR = 0.38; 95% CI: 0.21-0.71; 
p = 0.002 (†) 
21.1km ↑ risk 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General Muscle strengthening exercises (values not 
reported) 
- - 
Haglund-Åkerlind 
et al (1993) 
CS 2 
group 
54.5 General Strength training freq. (2.0 vs. 1.4d/wk) - - 
Knobloch et al 
(2008) 
CS 2 
group 
27.2 AT Discipline (1500-3000m; ref not reported) OR = 2.5; 95% CI: 1.09-5.84; p 
= 0.026 
↑ risk  
    Discipline (5km; ref not reported) OR = 1.8; 95% CI: 1.04-3.18; p 
= 0.034 
↑ risk 
    Discipline (half marathon; ref not reported) OR = 0.5; 95% CI: 0.28-0.92; p 
= 0.025 
↑ risk 
   PF Discipline (marathon; ref not reported) OR = 0.37; 95% CI: 0.18-0.77; 
p = 0.006 
↓ risk 
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McQuade (1986) CS 2 
group 
27.2 General Strength training (54.0% vs. 65.0%) - - 
AT, Achilles tendinopathy; CI, confidence interval; CS 2 group, cross-sectional two group comparison; GTP, group training program; HR, hazard ratio; IIR, injury incidence 
rate; OR, odds ratio; PC, prospective cohort; PF, plantar fasciitis; RCT, randomised controlled trial; RPE, rate of perceived exertion; RR, relative risk; (-) not 
reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S16 Extracted information on running-related injury studies that had considered age as an exposure 
Study  Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation  
Theisen et al (2013) RCT 91.6 General  Per 1.0yr ↑ - - 
Kelsey et al (2007) PC 91.6 SFX  Per 1.0yr ↓ (♀) HR = 1.42; 95% CI: 1.05-1.92 (†) Lower age ↑ risk 
Nielsen et al (2013b) PC 91.6 General 30.0-45.0 (ref) 18.0-30.0yr cIRD at 500km; -1.6%; 95% CI: -
12.3%-9.2%; p = 0.77  
- 
    30.0-45.0 (ref) 45.0-65.0yr cIRD at 500km; 14.7%; 95% CI: -
2.1%-31.5%; p = 0.08  
- 
Bredeweg et al (2013) PC 83.3 General 42.6 vs. 39.1yr (♂) - - 
    39.3yr vs. 35.2yr (♀) - - 
Buist et al (2010b) PC 83.3 General Per 1.0yr ↑ (♂) - - 
Hirschmüller et al 
(2012) 
PC 83.3 AT 48.1 vs. 42.8yr p = 0.013 - 
Wen et al (1998) PC 83.3 Multiple varied - - - 
lxxv 
 
injuries 
Malisoux et al (2013) PC 75.0 General Per 1.0yr ↑ HR = 0.99; p = 0.428 (†) - 
Kluitenberg et al 
(2015) 
PC 75.0 General Per 1.0yr ↑ HR = 1.02; 95% CI: 1.00-1.04; p = 
0.01 (†) 
Higher age ↑ risk  
Buist et al (2010a) PC 66.6 General Per 10.0yr ↑ (♂) HR = 0.63; 95% CI: 0.48-0.82; p = 
0.001 (†) 
Higher age ↓ risk 
    Per 10.0yr ↑ (♀) HR = 0.82; 95% CI: 0.66-1.02; p = 
0.07 (†) 
- 
Satterthwaite et al 
(1999) 
PC 58.3 Front thigh <25.0 (ref) 25.0-29.0yr  - - 
    <25.0 (ref) 30.0-34.0yr OR = 1.83; 95% CI: 1.04-3.22 (†) 30.0-34.0yr ↑ risk 
    <25.0 (ref) 35.0-39.0yr - - 
    <25.0 (ref) ≥40.0yr  - - 
   Calf <25.0 (ref) 25.0-29.0yr  - - 
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    <25.0 (ref) 30.0-34.0yr OR = 0.43; 95% CI: 0.23-0.78 (†) 30.0-34.0yr ↓ risk 
    <25.0 (ref) 35.0-39.0yr - - 
    <25.0 (ref) ≥40.0yr OR = 0.40; 95% CI: 0.23-0.73 (†) ≥40yr ↓ risk 
Taunton et al (2003) PC 58.3 General overall (‡) <31.0yr (♂) - - 
    31.0-37.0yr (♂) - - 
    38.0-43.0yr (♂) - - 
    44.0-50.0yr (♂) - - 
    >50.0yr (♂)  - - 
    >50.0yr (♀) OR = 1.92; 95% CI: 1.11-3.33 (†) >50yr ↑ risk  
   General new (‡) <31.0yr (♂) - - 
    <31.0yr (♀) RR = 0.58; 95% CI: 0.34-0.97 (†) <31yr ↓ risk 
    31.0-37.0yr - - 
    38.0-43.0yr - - 
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    44.0-50.0yr - - 
    >50.0yr - - 
Thijs et al (2011) PC 58.3 PFPS 41.6 vs. 37.5yr p = 0.20 - 
Van Ginckel et al 
(2009) 
PC 50.0 AT 38.0 vs. 40.0yr p = 0.88 - 
Ghani Zadah Hesar et 
al (2009) 
PC 41.6 General 40.6 vs. 38.7yr OR = 1.20; p = 0.39 - 
Thijs et al (2008) PC 33.3 PFPS 39.4 vs. 37.6yr  p = 0.49 - 
Hootman et al (2002) RC 83.3 General Per 10.0yr ↑ (♂) OR = 0.83; 95% CI: 0.78-0.88; p = 
0.0024 (†) 
Higher age ↓ risk 
    Per 10.0yr ↑ (♀) - - 
Taunton et al (2002) RC 50.0 PFPS 34.0 (ref) <34.0yr (♂) OR = 1.90; 95% CI: 1.15-3.14 (†) <34yr ↑ risk 
   ITBFS 34.0 (ref) <34.0yr (♂) OR = 2.77; 95% CI: 1.42-5.39 (†) - 
   PT 34.0 (ref) <34.0yr (♂) OR = 4.21; 95% CI: 1.97-8.89 (†) - 
lxxviii 
 
   MTSS 34.0 (ref) <34.0yr (♂) OR = 4.58; 95% CI: 1.77-11.81 (†) - 
   PF 34.0 (ref) <34.0yr (♂) OR = 0.39; 95% CI: 0.19-0.78 (†) <34yr ↓ risk 
   Meniscal 34.0 (ref) <34.0yr (♂) OR = 0.22; 95% CI: 0.08-0.57 (†) - 
   AT 34.0 (ref) <34.0yr (♂) OR = 0.36; 95% CI: 0.16-0.78 (†) - 
   Gluteus medius, 
SFX, spinal 
34.0 (ref) <34.0yr (♂) - - 
   PFPS 34.0 (ref) <34.0yr (♀) OR = 2.16; 95% CI: 1.33-3.49 (†) <34yr ↑ risk 
   Meniscal 34.0 (ref) <34.0yr (♀) OR = 0.44; 95% CI: 0.19-0.97 (†) <34yr ↓ risk 
   Multiple varied 
injuries 
34.0 (ref) <34.0yr (♀) - - 
Parker et al (2011) CS 2 group 81.8 General training-
related 
<25.0 (ref) 25.0-39.0yr (♀) OR = 1.37; 95% CI: 0.62-3.04; p = 
0.44 (†)  
- 
    <25.0 (ref) 40.0-54.0yr (♀) OR = 1.25; 95% CI: 0.52-3.02; p = 
0.61 (†) 
- 
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    <25.0 (ref) ≥55.0yr (♀) OR = 0.62; 95% CI: 0.10-3.96; p = 
0.61 (†) 
- 
   General marathon-
related 
<25.0 (ref) 25.0-39.0yr (♀) OR = 1.44; 95% CI: 0.47-4.43; p = 
0.52 (†) 
- 
    <25.0 (ref) 40.0-54.0yr (♀) OR = 0.88; 95% CI: 0.25-3.12; p = 
0.84 (†) 
- 
    <25.0 (ref) ≥55.0yr (♀) OR = 2.17; 95% CI: 0.18-26.43; p = 
0.54 (†) 
- 
Wen et al (1997) CS 2 group 81.8 Multiple varied 
injuries 
- - - 
Lloyd et al (1986) CS 2 group 72.7 General 33.7 vs. 31.6yr (♀) - - 
Marti et al (1988b) CS 2 group 72.7 General 34.8 vs. 35.0yr - - 
Gerlach et al (2005) CS 2 group 63.6 Multiple varied 
injuries 
- - - 
McKelvie & Valliant CS 2 group 63.3 General 30.2 vs. 36.1yr p = <0.01 Inj. group were 
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(1985) younger 
Bennell et al (2004) CS 2 group 54.5 TSFX 29.4 vs. 30.6yr (♀) p = 0.63 - 
Haglund-Åkerlind et al 
(1993) 
CS 2 group 54.5 AT 26.9 vs. 24.9yr - - 
Messier et al (1995) CS 2 group 54.5 ITBFS 33.9 vs. 35.0yr - - 
Ribeiro et al (2011a) CS 3 group 54.5 PF Current = 46.0; history = 40.0; 
no = 36.0yr (♂) 
p = 0.20 - 
    Current = 44.0; history = 34.0; 
no = 38.0yr (♀) 
p = 0.19 - 
Ribeiro et al (2011b) CS 3 group 54.5 PF Current = 44.4; history = 38.3; 
no = 35.0yr 
p = 0.19 - 
Ekenman et al (2001) CS 3 group 45.4 SFX - - - 
Grimston et al (1991) CS 2 group 36.3 SFX 26.9 vs. 32.8yr (♀) p <0.05 Inj. group were 
younger 
lxxxi 
 
Reinking & Hayes 
(2006) 
CS 2 group 36.3 ERLP 19.3 vs. 19.5yr - - 
   General Per 1.0yr ↑ (♀) HR = 0.84; 95% CI: 0.62-1.13 (†) - 
McCrory et al (1999) CS 2 group 27.2 AT 38.4 vs. 34.5yr - - 
McQuade (1986) CS 2 group 27.2 General 26.7 vs. 25.9yr - - 
AT, Achilles tendinopathy; CI, confidence interval; cIRD, cumulative injury risk difference; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-sectional 
three group comparison; ERLP, exercise-related leg pain; HR, hazard ratio; ITBFS, iliotibial band friction syndrome; MTSS, medial tibial stress syndrome; OR, odds ratio; 
PC, prospective cohort; PFPS, patellofemoral pain syndrome; PF, plantar fasciitis; RC, retrospective cohort; RCT, randomised controlled trial; RR, relative risk; SFX, stress 
fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score 
(higher numbers indicate superior quality); ‡ general overall and general new represent whether the participant was currently afflicted with injury or whether the injury was 
sustained during follow-up  
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Electronic Supplementary Material Table S17 Extracted information on running-related injury studies that had considered sex as an exposure 
Study Design Quality (%) 
(*) 
Injury type Exposure 
categories 
Estimate, 95% CI, and p-value Interpretation 
Theisen et al (2013) RCT  91.6 General  ♂ (ref) ♀ - - 
Nielsen et al (2013b) PC 91.6 General ♀ (ref) ♂ cIRD at 500km; -4.4%; 95% CI: -15.2%-
6.4%; p = 0.42 
- 
Hirschmüller et al 
(2012) 
PC 83.3 AT - - - 
Kluitenberg et al 
(2015) 
PC 75.0 General ♀ (ref) ♂ HR = 1.00; 95% CI: 0.66-1.53; p = 0.99 
(†) 
- 
Malisoux et al (2013) PC 75.0 General ♂ (ref) ♀ HR = 0.84; p = 0.51 - 
Bennett et al (2012) PC 66.6 In-season ERLP ♂ (ref) ♀ OR = 1.1; 95% CI: 0.3-4.3 - 
   In-season medial 
ERLP 
♂ (ref) ♀ OR = 3.6; 95% CI: 0.6-21.8 - 
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Buist et al (2010a) PC 66.6 General ♀ (ref) ♂ HR = 1.42; 95% CI: 1.02-1.99; p = 0.04 
(†) 
♂ ↑ risk  
Reinking et al (2007) PC 58.3 ERLP - - - 
Van Ginckel et al 
(2009) 
PC  50.0 AT  - - 
Ghani Zadah Hesar et 
al (2009) 
PC 41.6 General ♂ (ref) ♀ OR = 1.35; p = 0.59 - 
McKean et al (2006) CS 2 group 72.7 Multiple varied 
injuries 
♀ (ref) ♂ (<40yrs 
group) 
OR = 1.28; 95% CI: 1.06-1.54; p = 0.012 
(†) 
♂ ↑ risk 
    ♀ (ref) ♂ (>40yrs 
group) 
- - 
Rasmussen et al 
(2013) 
CS 2 group 72.7 General ♀ vs. ♂ RR = 0.77; 95% CI: 0.46-1.31; p = 0.34 - 
Jacobs & Berson 
(1986) 
CS 2 group 63.6 General - - - 
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Lopes et al (2011) CS 2 group  54.5 General ♂ (ref) ♀ RR = 1.35; 95% CI: 1.05-1.72  ♀ ↑ risk 
Messier et al (1995) CS 2 group  54.5 ITBFS - - - 
Satterthwaite et al 
(1999) 
CS 2 group 54.5 Hamstring ♀ (ref) ♂ OR = 1.60; 95% CI: 1.04-2.47 (†) ♂ ↑ risk 
   Hip ♂ (ref) ♀ OR = 1.88; 95% CI: 1.15-3.06 (†) ♀ ↑ risk 
   Calf ♀ (ref) ♂ OR = 1.86; 95% CI: 1.29-2.68 (†) ♂ ↑ risk 
AT, Achilles tendinopathy; CI, confidence interval; cIRD, cumulative injury risk difference; CS 2 group, cross-sectional two group comparison; ERLP, exercise-related leg 
pain; HR, hazard ratio; ITBFS, iliotibial band friction syndrome; OR, odds ratio; PC, prospective cohort; RC, retrospective cohort; RCT, randomised controlled trial; RR, 
relative risk; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate 
superior quality) 
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Electronic Supplementary Material Table S18 Extracted information on running-related injury studies that had considered height as an exposure 
Study Design Quality (%) (*) Injury type Exposure categories (inj. first) Estimate, 95% CI, and 
p-value 
Interpretation 
Kelsey et al (2007) PC 91.6 SFX Per 1.0cm ↓ (♀) HR = 1.04; 95% CI: 0.96-
1.12 (†) 
- 
Walter et al (1989) PC 91.6 General <170.0 (ref) 170.0-179.0cm (♂) RR = 2.04; 95% CI: 1.15-
3.46 (†) 
‘Average height’ ↑ risk 
    <170.0 (ref) ≥180.0cm (♂) RR = 2.30; 95% CI: 1.29-
3.90 (†) 
‘Tall’ ↑ risk  
    <160.0 (ref) 160.0-169.0cm (♀) - - 
    <160.0 (ref) ≥180.0cm (♀) - - 
Hirschmüller et al 
(2012) 
PC 83.3 AT 175.9 vs. 175.5cm - - 
Thijs et al (2011) PC 58.3 PFPS 166.0 vs. 167.0cm p = 0.5 - 
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Van Ginckel et al 
(2009) 
PC  50.0 General 167.1 vs. 168.3cm p = 0.65 - 
Ghani Zadah Hesar 
et al (2009) 
PC 41.6 General 168.6 vs. 168.4cm OR = 1.03; p = 0.91 - 
Thijs et al (2008) PC 33.3 PFPS 164.5 vs. 167.4cm p = 0.57 - 
Taunton et al 
(2002) 
RC 50.0 PF 157.0 (ref) <157.0cm (♂) OR = 5.25; 95% CI: 2.02-
13.67 (†) 
<157cm ↑ risk 
   Multiple varied 
injuries 
157.0 (ref) <157.0cm (♂) - - 
   PFPS 157.0 (ref) <157.0cm (♀) OR = 1.61; 95% CI: 1.03-
2.52 (†) 
<157cm ↑ risk 
   Multiple varied 
injuries 
157.0 (ref) <157.0cm (♀) - - 
Wen et al (1997) CS 2 group 81.8 Multiple varied 
injuries 
- - - 
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Lloyd et al (1986) CS 2 group 72.7 General 163.7 vs. 164.2cm (♀) - - 
Gerlach et al 
(2005) 
CS 2 group 63.6 Multiple varied 
injuries 
- - - 
Bennell et al (2004) CS 2 group 54.5 TSFX 169.1 vs. 165.1cm (♀) p = 0.06 - 
Duffey et al (2000) CS 2 group 54.5 AKP 172.0 vs. 174.0cm p = 0.03 Inj. group were shorter 
Haglund-Åkerlind 
et al (1993) 
CS 2 group 54.5 AT 183.0 vs. 183.0cm - - 
Messier et al  
(1995) 
CS 2 group  54.5 ITBFS 171.0 vs. 174cm p <0.03 Inj. group were shorter 
Ribeiro et al 
(2011a) 
CS 3 group 54.5 PF Current = 175.0; history = 166; no 
= 179.0cm (♂) 
p = 0.10 - 
    Current = 156.0; history = 176.0; 
no = 171.0cm (♀) 
p = 0.24  - 
Ribeiro et al 
(2011b) 
CS 3 group 54.5 PF Current = 168.0; history = 176.0; 
no = 171.0cm 
p = 0.17 - 
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Valliant (1981) CS 2 group 54.5 General 175.3 vs. 167.6cm p <0.001 Inj. group were taller 
Grimston et al 
(1991) 
CS 2 group 36.3 SFX 166.3 vs. 161.1cm - - 
McCrory et al 
(1999) 
CS 2 group 27.2 AT 174.5 vs. 174.5cm - - 
AKP, anterior knee pain; AT, Achilles tendinopathy; CI, confidence interval; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-sectional three group 
comparison; OR, odds ratio; PC, prospective cohort; PF, plantar fasciitis; PFPS, patellofemoral pain syndrome; RC,  
retrospective cohort; RR, relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, 
increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S19 Extracted information on running-related injury studies that had considered experience as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Theisen et al 
(2013) 
RCT 91.6 General Per 1.0yr ↑ HR = 1.00; p = 0.69 - 
    Regular runner prior 12mo (1.0 session 
p/w for 50% of the time) 
HR = 0.42; 95% CI: 0.23-0.78 
(†) 
Regularity ↓ risk 
    Competition/wk HR = 0.85; p = 0.80 - 
Kelsey et al (2007) PC 91.6 SFX Age started competing (per 1.0yr ↓) (♀) HR = 1.01; 95% CI: 0.93-1.10 
(†) 
- 
    Total # competitive seasons (per 1.0 unit 
↓) (♀) 
HR = 1.01; 95% CI: 0.93, 1.10 
(†) 
- 
Macera et al (1989) PC 91.6 General 3.0-9.0 (ref) 0.0-2.0yr (♂) OR = 2.2; 95% CI: 1.5-3.3 (†) Lower exp. ↑ risk 
    3.0-9.0 (ref) ≥10.0yr (♂) OR = 1.2; 95% CI: 0.8-1.9 (†) - 
xc 
 
    3.0-9.0 (ref) 0.0-2.0yr (♀) OR = 1.4; 95% CI: 0.3-6.4 (†) - 
    3.0-9.0 (ref) ≥10.0yr (♀) OR = 1.7; 95% CI: 0.5-6.1 (†) - 
Walter et al (1989) PC 91.6 General Run yr round (y vs. n) (♂) RR = 1.64; 95% CI: 1.12-2.35 
(†) 
Regularity ↑ risk  
    Run yr round (y vs. n) (♀) RR = 2.00; 95% CI: 1.01-3.75 
(†) 
Regularity ↑ risk 
Buist et al (2010b) PC 83.3 General Prev. active (axial loading (ref) non-axial 
load) (♂) 
HR = 2.02; 95% CI: 1.00-4.05 
(†) 
Non-axial loading ↑ risk 
    Prev. active (axial loading (ref) never) (♂) HR = 1.23; 95% CI: 0.54-2.78 
(†) 
- 
    Prev. active (axial loading (ref) non-axial 
load) (♀) 
- - 
    Previously active; axial loading (ref) never 
(♀) 
- - 
Hirschmüller et al PC 83.3 AT 12.7 vs. 9.3yr - - 
xci 
 
(2012) 
Wen et al (1998) PC 83.3 General High exp. (values not reported) RIIR = 1.88; 95% CI: 1.16-3.05; 
p <0.05 (†) 
Higher exp. ↑ risk 
   Foot  High exp. (values not reported) RIIR = 1.09; 95% CI: 1.03-1.15; 
p <0.05 (†) 
Higher exp. ↑ risk 
Hespanhol Junior 
et al (2013) 
PC 75.0 General Per 1.0yr ↑ OR = 0.99; 95% CI: 0.94-1.03; 
p = 0.601  
- 
Kluitenberg et al 
(2015) 
PC  75.0 General Exp. <12mo (y (ref) n) HR = 2.38; 95% CI: 1.24-4.57; 
p = 0.009 (†) 
Lower exp. ↑ risk  
    Exp. <12mo (y (ref) >12mo) HR = 1.41; 95% CI: 0.75-2.63; 
p = 0.28 (†) 
- 
    Prev. active (axial loading (ref) never) HR = 1.18; 95% CI: 0.80-1.74; 
p = 0.42 (†) 
- 
    Prev. active (axial loading (ref) non-axial) HR = 1.19; 95% CI: 0.77-1.86; 
p = 0.44 (†) 
- 
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Malisoux et al 
(2013) 
PC 75.0 General  Per 1.0yr ↑ HR = 0.99; p = 0.86 - 
    Half-marathon participation prior 12mo (n 
(ref) y) 
- - 
    Competitions (% of total volume) - - 
Van Middelkoop et 
al (2007) 
PC 75.0 General 3.0-10.0 (ref) 0.0-2.0yr OR = 0.79; 95% CI: 0.31-2.01; 
p = 0.62 (†) 
- 
    3.0-10.0 (ref) ≥10.0yr OR = 0.40; 95% CI: 0.12-1.30; 
p = .13 (†) 
- 
    # races (0.0-3.0 (ref) 4.0-7.0yr) OR = 0.97; 95% CI: 0.23-4.05; 
p = 0.97 (†) 
- 
    # races (0.0-3.0 (ref) ≥8.0yr) OR = 0.65; 95% CI: 0.15-2.91; 
p = 0.58 (†) 
- 
    # races prior 12mo (0.0-2.0 (ref) 3.0-6.0) OR = 0.63; 95% CI: 0.13-3.10; 
p = 0.57 (†) 
- 
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    # races prior 12mo (0-2 (ref)  ≥7.0) OR = 0.59; 95% CI: 0.13-2.59; 
p = 0.48 (†) 
- 
    Races of 0.0-5.0km (no (ref) yes) OR = 2.61; 95% CI: 0.22-30.71; 
p = 0.45 (†) 
- 
Buist et al (2010a) PC 66.6 General Current participation (ref) restarted 
running (♂) 
HR = 2.24; 95% CI: 1.13-4.45; 
p = 0.02 (†) 
Resuming activities ↑ 
risk  
    Current participation (ref) no exp. (♂) HR = 2.61; 95% CI: 1.23-5.53; 
p = 0.012 (†) 
No exp. ↑ risk 
    Prev. active (axial loading (ref) prev. 
active non-axial loading) (♂) 
HR = 0.88; 95% CI: 0.41-1.93; 
p = 0.76 (†) 
- 
    Prev. active (axial loading (ref) not 
previously active) (♂) 
HR = 1.08; 95% CI: 0.57-2.04; 
p = 0.81 (†) 
- 
    Current participation (ref) restarted 
running (♀) 
HR = 1.15; 95% CI: 0.65-2.02; 
p = 0.63 (†) 
- 
    Current participation (ref) no experience HR = 2.14; 95% CI: 1.24-3.70; No exp. ↑ risk  
xciv 
 
(♀) p = 0.007 (†) 
    Prev. active (axial loading (ref) prev. 
active non-axial loading) (♀) 
HR = 1.85; 95% CI: 1.07-3.21; 
p = 0.029 (†) 
Non-axial loading ↑ risk 
    Prev. active (axial loading (ref) not prev. 
active) (♀) 
HR = 1.53; 95% CI: 0.88-2.66; 
p = 0.130 (†) 
- 
Reinking et al 
(2007) 
PC 58.3 ERLP Yrs collegiate running (1st-2nd (ref) 3rd-4th) 
(quartiles of years running) 
RR = 1.74; 95% CI: 0.81-3.73 - 
Satterthwaite et al 
(1999) 
PC 58.3 Hamstring Debut marathon (y vs. n) OR = 1.55; 95% CI: 1.08-2.22; 
p <0.02 (†) 
Lower exp. ↑ risk  
   Knee Debut marathon (y vs. n) OR = 1.66; 95% CI: 1.16-2.38; 
p <0.005 (†) 
Lower exp. ↑ risk 
Hootman et al 
(2002) 
RC 83.3 General # races prior 12.0mo (>3.0 vs. <3.0) (♂) OR = 1.03; 95% CI: 1.00-1.06; 
p = 0.04 (†) 
Higher # races ↑ risk  
    # races prior 12.0mo (>3.0 vs. <3.0) (♀) OR = 1.18; 95% CI: 1.07-1.31; 
p <0.001 (†) 
Higher # races ↑ risk 
xcv 
 
Taunton et al 
(2002) 
RC 50.0 MTSS 8.5 (ref) <8.5yr (♂) OR = 3.53; 95% CI: 1.28-9.75 
(†) 
Lower exp. ↑ risk 
   Multiple varied 
injuries 
8.5 (ref) <8.5yr (♂) - - 
   MTSS 8.5 (ref) <8.5yr (♀) OR = 2.50; 95% CI: 1.07-5.82 
(†) 
Lower exp. ↑ risk 
   Multiple varied 
injuries 
8.5yr (ref) <8.5yr (♀) - - 
Myburgh et al 
(1990) 
CC 50.0 SFX # competitions (values not reported) - - 
    3.0 vs. 3.0yr - - 
Miller et al (2007) CC 40.0 ITBFS Current mileage (6.0 vs. 6.3mo) p = 0.87 - 
Parker et al (2011) CS 2 
group 
81.8 General 
training-related 
Prev. marathon exp. (n (ref) y) (♀) OR = 0.63; 95% CI: 0.38-1.04; 
p = 0.07 (†) 
- 
   General Prev. marathon exp. (n (ref) y) (♀) OR = 0.70; 95% CI: 0.35-1.40; - 
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marathon-
related 
p = 0.31 (†) 
Wen et al (1997) CS 2 
group 
81.8 Hip Least exp. (tertiles not reported) OR = 0.17; p = 0.03 (†) Lower exp. ↓ risk  
    Most exp. (tertiles not reported) OR = 0.24, P = 0.07 (†) Higher exp. ↓ risk 
Lloyd et al (1986) CS 2 
group 
72.7 General 5.6 vs. 4.0yr (♀) p <0.009 Inj. group had a higher 
exp. 
    5.6 vs. 4.0yr (♀) p <0.0013 (†) Inj. group had a higher 
exp. 
    Age started (27.8 vs. 27.6yr) (♀) - - 
Marti et al (1988b) CS 2 
group 
72.7 General 7.0 vs. 6.8yr - - 
McKean et al 
(2006) 
CS 2 
group 
72.7 Multiple varied 
injuries 
- - - 
Rasmussen et al CS 2 72.7 General Prev. marathon exp. (y vs. n) RR = 0.60; 95% CI: 0.37-0.95; Higher exp. ↓ risk 
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(2013) group p = 0.03 (†) 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General Overall exp. (values not reported) - - 
    Prev. marathon participation (values not 
reported) 
- - 
    >10 races prior 12mo (~35% vs. ~25%) p <0.025 Higher % of the inj. 
group raced 
Bennell et al 
(2004) 
CS 2 
group 
54.5 TSFX Yrs >20km p/w (8.2 vs. 6.7yr) (♀) p = 0.13 - 
Duffey et al (2000) CS 2 
group 
54.5 AKP 9.6 vs. 9.6yr - - 
Haglund-Åkerlind 
et al (1993) 
CS 2 
group 
54.5 AT 8.9 vs. 5.2yr  p <0.01 Inj. group had a higher 
exp. 
    Personal best (800m & 1500m) - - 
Lopes et al (2011) CS 2 54.5 General 45.0 vs. 36.0mo P <0.001 Higher exp. ↑ risk 
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group 
Messier et al  
(1995) 
CS 2 
group 
54.5 ITBFS 7.8 vs. 10.6yr p = 0.003 Inj. group had a lower 
exp. 
Niemuth et al 
(2005) 
CS 2 
group 
54.5 Multiple varied 
injuries 
- - - 
Grimston et al 
(1991) 
CS 2 
group 
36.3 SFX 7.2 vs. 6.6yr (♀) - - 
Messier et al  
(1991) 
CS 2 
group 
36.3 PFPS 8.6 vs. 8.4yr - - 
Reinking & Hayes 
(2006) 
CS 2 
group 
36.3 ERLP 6.0 vs. 5.8yr - - 
Knobloch et al 
(2008) 
CS 2 
group 
27.2 Back >10yr (ref not reported) OR = 3.3; 95% CI: 1.16-4.57; p 
= 0.01 
Higher exp. ↑ risk 
   AT >10yr (ref not reported) OR = 1.6; 95% CI: 1.02-2.76; p 
= 0.04 
Higher exp. ↑ risk 
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McCrory et al 
(1999) 
CS 2 
group 
27.2 AT 11.9 vs. 9.6yr p <0.05 Inj. group had a higher 
exp.  
McQuade (1986) CS 2 
group 
27.2 General 6.3 vs. 4.6yr - - 
Messier & Pittala 
(1988) 
CS 3 
group 
27.2 MTSS, ITBFS, 
PF 
Control = 8yr; MTSS = 4yr; ITBFS = 5yr; 
PF = 7yr 
- - 
AKP, anterior knee pain; AT, Achilles tendinopathy; CC, case-control; CI, confidence interval; CS 2 group, cross-sectional two group comparison; CS 3 group, cross-
sectional three group comparison; ERLP, exercise-related leg pain; Exp, experience; HR, hazard ratio; ITBFS, iliotibial band friction syndrome; MTSS, medial tibial stress 
syndrome; OR, odds ratio; PC, prospective cohort; PFPS, patellofemoral pain syndrome; PF, plantar fasciitis; RC, retrospective cohort; RCT, randomised controlled trial; RR, 
relative risk; SFX, stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), 
methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S20 Extracted information on running-related injury studies that had considered previous injury as an exposure 
Study Design Quality (%) 
(*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-value Interpretation 
Theisen et al 
(2013) 
RCT  91.6 General Prior 12mo (n (ref) y) HR = 1.74; 95% CI: 1.03-2.90 (†) Previous injury 
↑ risk 
Kelsey et al (2007) PC 91.6 SFX History of  ≥1.0 prior SFX (♀) HR = 6.42; 95% CI: 1.80-22.87 
(†) 
Previous injury 
↑ risk 
Macera et al (1989) PC 91.6 General Prior 12.0mo (y vs. n) (♂) OR = 2.7; 95% CI: 2.6-2.7 (†) Previous injury 
↑ risk 
    Prior 12.0mo (y vs. n) (♀) OR = 1.9; 95% CI: 0.7-4.9 (†) - 
Nielsen et al 
(2013b) 
PC 91.6 General Prev. inj. (n (ref) y) cIRD at 500km; 5.2%; 95% CI: -
8.9%-19.3%; p = 0.47 
- 
    Prev. non running-related inj. (n (ref) y) cIRD at 500km; 11.1%; 95% CI: 
-0.2%-22.4%; p = 0.05 
Previous injury 
↑ risk 
Walter et al (1989) PC 91.6 General Prior 12.0mo (y vs. n) (♂) RR = 1.69; 95% CI: 1.27-2.25 (†) Previous injury 
ci 
 
↑ risk 
    Prior 12.0mo (y vs. n) (♀) RR = 2.35; 95% CI: 1.33-4.07 (†) - 
Buist et al (2010b) PC 83.3 General never (ref) >3.0-≤12.0mo (♂) HR = 2.64; 95% CI: 1.32-5.30 (†) Previous injury 
↑ risk 
    never (ref) >12.0mo (♂) HR = 2.14; 95% CI:1.05-4.35 (†) Previous injury 
↑ risk 
    never (ref) >3.0-≤12mo (♀) - - 
    never (ref) >12.0mo (♀) - - 
Hirschmüller et al 
(2012) 
PC 83.3 AT Prev. Inj. Achilles (y vs. n) OR = 3.8; 95% CI: 1.7-8.5; p = 
0.001 (†) 
Previous injury 
↑ risk 
Van Middelkoop et 
al (2008) 
PC 83.3 General Prior 12.0mo (y vs. n)  OR = 2.62; 95% CI: 1.82-3.78 (†) Previous injury 
↑ risk 
Wen et al (1998) PC 83.3 General Prev. inj. (inj./weeks accumulated) RIIR = 2.01; 95% CI: 1.27-3.21; 
p <0.05 (†) 
Previous injury 
↑ risk 
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   Shin Prev. inj. (inj./weeks accumulated) RIIR = 7.2; 95% CI: 2.40-21.82; 
p <0.05 (†) 
Previous injury 
↑ risk 
Hespanhol Junior 
et al (2013) 
PC 75.0 General Total # (n (ref) y) OR = 1.88; 95% CI: 1.01-3.51; p 
= 0.046 (†) 
Previous injury 
↑ risk 
Kluitenberg et al 
(2015) 
PC 75.0 General Prev. musculoskeletal complaints (no (ref) 
yes, not attributable to sports) 
HR = 1.78; 95% CI: 1.26-2.53; p 
= 0.001 (†) 
Previous injury 
↑ risk 
    Prev. musculoskeletal complaints (no (ref) 
yes, attributable to sports) 
HR = 1.19; 95% CI: 0.80-1.77; p 
= 0.400 (†) 
- 
    Prev. inj. (n (ref) y) HR = 1.29; 95% CI: 0.75-2.22; p 
= 0.36 (†) 
- 
Malisoux et al 
(2013) 
PC 75.0 General Prior 12mo (n (ref) y) HR = 1.72; 95% CI: 1.11-2.66 (†) Previous injury 
↑ risk 
Van Middelkoop et 
al (2007) 
PC 75.0 General Prior 12.0mo (n (ref) y) (♂) OR = 1.41; 95% CI: 0.48-4.09; p 
= 0.53 (†) 
- 
    Inj. at baseline (n (ref) y) OR = 1.62; 95% CI: 0.61-4.33; p - 
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= 0.34 (†) 
Bennett et al 
(2012) 
PC 66.6 In-season ERLP ERLP prior 12.0mo  OR = 12.3; 95% CI: 3.1-48.9 (†) Previous injury 
↑ risk 
   In-season 
medial ERLP 
ERLP prior 1.0mo OR = 10.3; 95% CI: 1.7-61.9 (†) Previous injury 
↑ risk 
Buist et al (2010a) PC 66.6 General never (ref) <1.0yr (♂) HR = 0.66; 95% CI: 0.34-1.31; p 
= 0.24 
- 
    never (ref) ≥1.0yr (♂) HR = 0.98; 95% CI: 0.57-1.69; p 
= 0.94 
- 
    never (ref) <1.0yr (♀) HR = 1.29; 95% CI: 0.81-2.05; p 
= 0.28 
- 
    never (ref) ≥1.0yr (♀) HR = 0.86; 95% CI: 0.52-1.43; p 
= 0.57 
- 
Reinking et al 
(2007) 
PC 58.3 ERLP ERLP history (y (ref) n) RR = 2.34; 95% CI: 1.01-5.42 Previous injury 
↑ risk 
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Hootman et al 
(2002) 
RC 83.3 General Prior 12.0mo (y vs. n) (♂) OR = 2.09; 95% CI: 1.63-2.68; p 
<0.001 (†) 
Previous injury 
↑ risk 
    Prior 12.0mo (y vs. n) (♀) OR = 2.81; 95% CI: 1.68-4.71; p 
<0.001 (†) 
Previous injury 
↑ risk 
Taunton et al 
(2002) 
RC 50.0 Multiple varied 
injuries 
Prev. inj. same anatomical location - - 
Parker et al (2011) CS 2 group 81.8 General 
training-related 
Prior 12.0mo (no (ref) mild) (♀) OR = 3.54; 95% CI: 1.90-6.61; p 
<0.001 (†) 
Previous injury 
↑ risk 
    Prior 12.0mo (no (ref) severe) (♀) OR = 5.08; 95% CI: 2.95-8.73; p 
<0.001 (†) 
Previous injury 
↑ risk 
   General 
marathon-
related  
Inj. during training (no (ref) mild) (♀) OR = 3.79; 95% CI: 1.60-9.01; p 
= 0.003 (†) 
Previous injury 
↑ risk 
    Inj. during training (no (ref) severe) (♀) OR = 7.09; 95% CI: 3.30-15.25; p 
<0.001 (†) 
Previous injury 
↑ risk 
cv 
 
Marti (1988a) CS 2 group 72.7 General - p <0.05 Higher % inj. 
prev. inj. 
Marti et al (1988b) CS 2 group 72.7 General 20.8% vs. 12.7% P <0.001 Higher % inj. 
prev. inj. 
Rasmussen et al 
(2013) 
CS 2 group 72.7 General Prior 12mo (y vs. n) RR = 2.23; 95% CI: 1.41-3.52; p 
<0.01 (†) 
Previous injury 
↑ risk 
AT, Achilles tendinopathy; CI, confidence interval; cIRD, cumulative injury risk difference; CS 2 group, cross-sectional two group comparison; ERLP, exercise-related leg 
pain; HR, hazard ratio; OR, odds ratio; PC, prospective cohort; RCT, randomised controlled trial; RR, relative risk; RIIR, relative injury incidence rate; (-) not 
reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S21 Extracted information on running-related injury studies that had considered biomedical factors as an exposure 
Study Design Quality 
(%) (*) 
Injury 
type 
Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Kelsey et al 
(2007) 
PC 91.6 SFX BMC whole body (per SD 293.2g ↓) (♀) HR = 2.70; 95% CI: 1.26-
5.88 (†) 
Lower whole-body BMC ↑ 
risk 
    BMC hip (per SD 5.78g ↓) (♀) RR = 1.69; 95% CI: 0.95-
2.94 (†) 
- 
    BMD hip (per SD 0.12g.cm-2 ↓) (♀) RR = 1.45; 95% CI: 0.81-
2.56 (†) 
- 
Hirschmüller et al 
(2012) 
PC 83.3 AT Neovascularisation  OR = 6.9; 95% CI: 2.6-
18.8; p <0.001 (†) 
Higher intratendinous micro-
vessels ↑ risk 
    Hyper/hypoechogenicity p = 0.988 - 
    Maximum tendon thickness - - 
    Spindle-shaped thickening - - 
Satterthwaite et al 
(1999) 
PC 58.3 Calf Illness prior to race (y vs. n) OR = 1.42; 95% CI: 1.03-
1.95; p <0.03 (†) 
↑ risk  
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Myburgh et al 
(1990) 
CC 50.0 SFX BMD lumbar spine (1.01 vs. 1.11gm/cm2) p = 0.02 Inj. had lower BMD 
    BMD proximal femur (0.93 vs. 0.13gm/cm2) p = 0.02 Inj. had lower BMD 
    BMD femoral neck (0.83 vs. 0.89gm/cm2) p = 0.005 Inj. had lower BMD 
    BMD trochanter (0.69 vs. 0.75gm/cm2) p = 0.01 Inj. had lower BMD 
    BMD ward triangle (0.67 vs. 0.73gm/cm2) p = 0.01 Inj. had lower BMD 
Bennell et al 
(2004) 
CS 2 
group 
54.5 TSFX BMD lumbar spine [L1-L4] (1.053 vs. 1.039gm/cm2) 
(♀) 
p = 0.54 - 
    BMD total hip (1.144 vs. 1.098gm/cm2) (♀) p = 0.81 - 
    BMD femoral neck (0.938 vs. 0.922gm/cm2) (♀) p = 0.77 - 
    BMD trochanter (0.825 vs. 0.801gm/cm2) (♀) p = 0.65 - 
    BMD tibia; region [R1] isolated marker (1.216 vs. 
1.152gm/cm2) (♀) 
p = 0.57 - 
    BMD tibia; region [R2] entire distal third (0.929 vs. p = 0.57 - 
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0.879gm/cm2) (♀) 
    Anterior-posterior tibial width (2.32 vs. 2.32) (♀) p = 0.91 - 
    Medio-lateral tibial width (2.21 vs. 2.17) (♀) p = 0.42 - 
    Total cross-sectional tibial area (3.63 vs. 3.51cm2) (♀) p = 0.28 - 
    Cortical area of tibia (3.07 vs. 2.94cm2) (♀) p = 0.19 - 
Grimston et al 
(1991) 
CS 2 
group 
36.3 SFX BMD lumbar spine (0.92 vs. 0.85gm/cm2) (♀) p <0.05 Inj. had higher BMD 
    BMD femoral neck (0.85 vs. 0.79gm/cm2) (♀) p <0.05 - 
    BMD tibial diaphysis (18.67 vs. 17.02gm/cm2) (♀) - - 
AT, Achilles tendinopathy; BMC, bone mineral content; BMD, bone mineral density; CI, confidence interval; CS 2 group, cross-sectional two group comparison; CS 3 
group, cross-sectional three group comparison; OR, odds ratio; PC, prospective cohort; RCT, randomised controlled trial; RR, relative risk; RRI, running-related injury; SFX, 
stress fracture; TSFX, tibial stress fracture; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; (*), methodological quality 
score (higher numbers indicate superior quality) 
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Electronic Supplementary Material Table S22 Extracted information on running-related injury studies that had considered other non-modifiable factors as an exposure 
Study Design Quality 
(%) (*) 
Injury type Exposure categories (inj. first) Estimate, 95% CI, and p-
value 
Interpretation 
Van Middelkoop et 
al (2008) 
PC 83.3 General High education OR = 0.76; 95% CI: 0.55-1.07; 
p = 0.11 (†) 
- 
Lloyd et al (1986) CS 2 
group 
72.7 General # children (0.40 vs. 0.49) - - 
Gerlach et al 
(2005) 
CS 2 
group 
63.6 General VO2max (values not reported) - - 
Jacobs & Berson 
(1986) 
CS 2 
group 
63.6 General Marital status, education, occupation, 
income (values not reported) 
- - 
Marti & Rehmann 
(1987) 
CS 2 
group 
36.3 General Endurance capacity (values not reported) SRC -.064; p = 0.002 Higher fitness ↓ risk 
    Fitness level (low vs. medium vs. high) - - 
CI, confidence interval; CS 2 group, cross-sectional two group comparison; HR, hazard ratio; OR, odds ratio; PC, prospective cohort; RR, relative risk; SRC, standardised 
regression coefficient; VO2max, maximal oxygen uptake per minute; (-) not reported/statistically significant; (†), adjusted measure of association; ↑, increase; ↓, decrease; 
(*), methodological quality score (higher numbers indicate superior quality) 
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